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Abstract
Background
Birth by Cesarean section (CS) has been associated with a greater risk for immune disorders 
like allergy, asthma, type 1 diabetes, celiac disease, inflammatory bowel diseases, and cancer 
later in life. Although elective CS continues to increase rapidly, it is unclear if and how it may 
contribute to future health and disease. Our aim was to investigate the influence of mode 
of delivery on the global epigenetic state in white blood cells (WBC) as well as global and 
genome-wide, locus-specific epigenetic state in hematopoietic stem/progenitor cells. Further, 
we tested whether surge of immune cell formation at birth is related to mode of delivery, tak-
ing other maternal and infant characteristics in account.
Objective and methods
Study I and II are observational cohort studies including 37 (16 elective CS) and 64 (27 elec-
tive CS) healthy infants born at term. Cord blood was sampled and in study I, blood sampling 
was repeated 3-5 days after birth. Global DNA-methylation was analyzed in leukocytes by lu-
minometric methylation assay (LUMA). In study II and in addition to LUMA, genome-wide, 
locus-specific DNA-methylation analysis of hematopoietic CD34+ cells was performed after 
cell separation using the Illumina Infinium 450K platform.
In study III, we used a prospectively collected database, including information on maternal 
and infant characteristics of 6,014 healthy, singleton infants delivered in Stockholm, Sweden, 
with gestational age ≥ 35 weeks. The data was linked to blood levels of T-cell receptor excision 
circles (TREC) and κ-deleting recombination excision circles (KREC), determined 3-5 days 
after birth as part of a neonatal screening program for immune-deficiencies, and representing 
quantities of newly formed naïve T- and B-lymphocytes.
Results
Global DNA-methylation of leucocytes and hematopoietic stem cells (CD 34+) was higher in 
infants delivered by elective CS compared to those born vaginally. The genome-wide, locus-
specific analysis identified 343 loci with a > 10 % (maximal 40 %) difference of DNA-methyl-
ation between the two groups. In vaginally delivered infants, the degree of DNA-methylation 
in three loci gradually diminished in relation to duration of labor.
Infants born by CS before labor had a 32 % increased risk of having TRECs within the lowest 
quintile. Low TREC was also independently associated with male gender, preterm birth at 
35-36 weeks of gestation and infant being small for gestational age. Low KREC was associ-
ated with male gender, postterm birth at > 42 weeks and small for gestational age. Maternal 
characteristics exhibited no associations with levels of TREC or KREC in newborn infants.
Conclusions
Mode of delivery affected the epigenetic state of the neonatal WBC and hematopoietic stem/
progenitor cells. In addition, delivery by elective CS was associated with lower T-lymphocyte 
formation in newborn infants. The significance and functional relevance of epigenetic differ-
ences and reduced birth-related surge in lymphocyte formation for future health in children 
and adults delivered by CS remains to be explored.
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11 Introduction
Cesarean section (CS) has become the most common surgical procedure in wom-
en of child-bearing age and the rates are increasing rapidly in many countries 
worldwide.
Short-term maternal and infant outcomes after CS are well described. The 
long-term consequences of this change in mode of childbirth are however still 
mostly unknown.
Compared to vaginal delivery (VD), CS delivered infants have an increased 
risk developing immune associated disorders later in life, such as asthma and al-
lergies, type 1 diabetes, celiac disease and inflammatory bowel diseases, immune 
deficiencies, leukemia, and other malignancies affecting young people. Also, 
associations between CS and increased risk of obesity and autism have been re-
ported. If and how CS could affect the health in the offspring is, however, still 
unclear as the underlying mechanisms are poorly understood.
Possible pathways and mechanisms explaining or contributing to the above-
mentioned associations that have been suggested in earlier studies include the 
altered bacterial colonization of the neonatal gut – “the hygiene hypothesis” – 
and the lack of birth stress induced by labor and preparing the fetus for the world 
outside the womb. In relation to reduced birth stress, we hypothesized that this 
may result in maladaptive immune activation through modified epigenetic regu-
lation of gene expression in white blood cells.
In this thesis, I will present two studies on mode of delivery and epigenetic 
state of newborn, and one study on how various perinatal risk factors, including 
CS before labor, affect the establishment of differentiated immune cells at birth.
22 Background
2.1 Developmental origins of adult health and disease
The concept of developmental origins of adult disease has its background in the 
epidemiological findings by David Barker and colleagues. They discovered that 
low birth size is related to a greater risk of death from cardiovascular disease1 and 
type 2 diabetes mellitus2 in adult age. Several epidemiological and clinical stud-
ies have led to the conclusion that the risk of developing diseases in adulthood 
can be influenced not only by genetics and adult lifestyle factors, but also by en-
vironmental factors acting in early life, even before birth via developmental plas-
ticity.3, 4
Intrauterine or early childhood events can cause an adaption to an environ-
ment that can be predicted by the means of the event. This is a key concept of the 
developmental origins of adult health and disease. The concept, called “predic-
tive adaptive response”,3 is evolutionary important since the adaptive response 
will predict the future environment and therefore optimize phenotype, which in 
turn will promote survival. A faulty prediction in early life may lead to a discrep-
ancy between expected and real environment, resulting in early shaping of a phe-
notype which will have more narrow physiological boundaries in future life and 
therefore an increased risk of disease. For instance, a nutritionally sparse fetal 
life will cause an adaption to a postnatal life lacking adequate resources. If nutri-
tion is not sparse in the postnatal environment, an energy conserving phenotype 
programmed early in fetal life by predictive adaptive response could be unfavor-
able and more easily lead to obesity and the metabolic syndrome. The changes of 
the predictive adaptive response may be permanent if they occur during critical 
developmental periods. This is now supported by a large amount of clinical and 
experimental data.4 There is also increasing evidence from experimental studies 
in animal and humans that early environmental factors act to alter physiology 
through epigenetic processes.5
In the agouti mouse model (viable yellow agouti (A(vy)) carrying a ret-
rotransposon that regulates the agouti gene, normally expressed only in hair fol-
licles), food poor in methyl supplements given to pregnant mice reduces the level 
of DNA-methylation in the retrotransposon which leads to an ectopic gene ex-
pression and changes the phenotype of the offspring into an obese diabetic mouse 
3with increased risk of cancer.6 This experiment demonstrates that the fetal nutri-
tional environment may cause a lasting change of the offspring s´ phenotype by 
an epigenetic mechanism. The in utero environmentally induced phenotype and 
the levels of DNA-methylation were also found in the second generation of off-
springs.7 
The research group of Meaney and Szyf demonstrated that not only fetal nu-
trition but also adverse neonatal stress could result in an increased stress-sen-
sitivity of the adult offspring.8 Rat pups raised by mothers who provided affec-
tionate care in form of licking and grooming the first days after birth showed 
a different and lower degree of DNA-methylation in the promoter region of the 
glucocorticoid receptor gene (GR) in the hippocampus and the GR expression 
was increased as compared to pups to less affectionate mothers. The pups reared 
under these neonatal conditions became less stress sensitive as adults than pups 
reared by less attentive mothers and these findings could be replicated in a study 
design with cross-fostering. Meaney and Szyf went on to study the homologous 
region of the hippocampal promoter in men who had committed suicide. Suicide 
victims with a history of abuse in childhood showed an increased DNA-methyla-
tion similar to that found in the rat experiment, whereas suicide victims without 
a history of child abuse did not.9 
An increased level of DNA-methylation was also found in the same promot-
er region of the glucocorticoid receptor gene in mononuclear cord blood cells in 
newborn infants born by mothers with depressive symptoms in the third trimes-
ter.10 Such DNA hypermethylation was associated with increased salivary cortisol 
levels after exposure to stress at 3 months of age.
A recently published review, including 23 studies, on the relationship between 
certain early-life exposures (early-life socio-economic circumstances, childhood 
obesity, and early-life nutrition) and DNA-methylation in human subjects, sup-
ports that epigenetics, specifically DNA-methylation, is a plausible mechanism 
through which early life environment can act and influence health outcomes 
years after the exposures.11
In summary, evidence is increasing for a number of different early-life events 
and exposures leading to epigenetic modifications that are long-lasting and there-
fore can have health-related consequences later in adult life. 
2.2 The “stress” of being born
Being born is sometimes described as an affliction.12 The human baby is driven 
through the birth canal often for many of hours, with the head exposed to sub-
stantial pressure. From a low starting point of arterial partial pressure of oxygen, 
the fetus is exposed to repeated hypoxic episodes along with uterine contractions 
4and may be at risk of asphyxia if the placental circulation or umbilical cord is de-
pressed too much. From that perspective, birth stands in strong contrast to prena-
tal life.  From a warm and protected environment, the newborn infant is delivered 
to a colder and much less protected environment outside.12 
The birth can be described as “stressful” for the infant, but what do we know 
about the “stress“ of being born?
The biological stress of being born surpass all other stress later in life (Fig 1). 
It is fundamental for intact survival during the transition from fetal to neonatal 
life. The fetus and the newborn infant have large stores of catecholamines in the 
adrenal glands and in the paraganglia along the aorta.13 Lagercrantz and Slotkin 
measured the levels of catecholamine in umbilical cord blood after normal VD. 
They discovered that the levels of catecholamines immediately after birth were 
much higher than in adults during different kinds of stressful activities. The lev-
els of catecholamines after VD were even higher than in patients with pheochro-
mocytoma, a catecholamine producing tumor (Fig 1). 
On the contrary, infants, delivered by elective CS, had only slightly elevated 
levels of catecholamines compared to resting adults.14 After emergency CS, often 
after established labor, the catecholamine levels increased substantially, similar to 
those after VD. The findings suggest that the uterine contractions, together with 
some hypoxia, cause the release of catecholamines.12 It is known that vaginally 
delivered infants adapt easier to extrauterine life, for example by start breath-
ing more easily. This can be explained by the stimulation of adrenaline on the 
absorption of lung fluid.13, 15 Infants delivered by elective CS show more often 
transient respiratory distress and their glucose levels are slightly lower,16 see sec-
tion 2.3.2. Another marker of stress, cortisol, measured in cord blood is signifi-
cantly lower in infants delivered by elective CS.17 Also, elective CS infants have a 
lower body temperature, probably due to decreased noradrenaline levels, result-
ing in less stimulation of brown fat that generates body heat.12, 18 Labor activates 
the inflammatory defense systems19 and the central nervous system20 so that the 
Fig 1.  
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5fetus is most favorable prepared and suited for life outside the uterus. Compared 
to normal VD, stress in infants delivered by elective CS is immediate rather than 
gradually developed as during labor. CS may therefore be maladaptive for the 
newborn infant.  
In summary, the physiological release of catecholamines brings a lot of ben-
efits for the newborn infant and we may therefore call the “stress” of being born 
a “good stress”.12
2.3 Mode of delivery
The two principal modes of delivery are vaginal delivery and cesarean section. 
Of all the deliveries in 2015 in Sweden, there were 82.6 % VDs, of which 75.4 
% were non-instrumental and 7.2 % instrumental, mainly vacuum extractions.21 
The most common indications for instrumental VD were prolonged labor, dys-
tocia, or signs of fetal hypoxia. In 83.7 % of VD, the labor started spontaneously, 
whereas 16.3 % had an induced labor. Causes of induction were post-term gesta-
tion (duration of pregnancy exceeded 42 + 0 weeks), multiple pregnancy, unclear 
bleeding during pregnancy, declining fetal growth or emerging disease in the 
mother, e.g. preeclampsia or diabetes.21 Uterine contractions were mainly start-
ed artificially by drug treatment, but amniotomy and the use of balloon catheters 
were also used. 
In total, 17.4 % of pregnant women underwent CS, of which 7.8 % were elec-
tive and 9.4 % emergency CS.21 Causes of planned/elective CS included breech 
position, preeclampsia, multiple birth after complicated pregnancy, placenta po-
sition impeding VD (placenta previa), psychosocial indication, former CS, small 
maternal pelvis, or large baby. Indications for emergency CS included complica-
tions during VD, such as elongated delivery, weakness of labor, severe bleeding, 
uterine rupture, and/or threatening asphyxia of the fetus.
2.3.1 Frequency of Cesarean section –  
 international perspective
The rate of CS has quadrupled worldwide in less than two decades. Data from 
the first decade of the 21st century are presented in fig 2. That makes CS the most 
common surgical procedure performed in women of child-bearing age.22-24 
Until the beginning of the 20th century CS was very uncommon.25 In the 
period between 1926 and 1930 the CS rate in Sweden was 0.25 %.26 Community 
hospitals in Detroit, USA, with more than 30 000 deliveries per year 1926 - 1930 
performed CS in 0.45 % to 0.6 % of their deliveries.25 During the period 1951 to 
1980, CS rates increased from 1.7 to 11 % in Sweden.26 In the last five years, Swed-
ish CS rates have been stable around 17 – 18 %.21
6CS has been estimated to be medically indicated in up to 20 % of all deliver-
ies.27, 28 However, many national CS-rates exceed this level, suggesting that many 
women probably undergo CS without a clear medical indication.24, 29 (Fig 2) In 
2009, Brazil was the first country where the rate of CS, comprising 50.1 % of all 
deliveries, surpassed the quantity of VD. The rate has since then continue to in-
crease, with statistics from 2014 reporting a CS rate of 55.7 %.30
There are several potential causes for the increasing rates of CS:
•  Changes in the risk profiles of the mother-to-be as maternal age, obesi-
ty and diabetes are considered to be important contributors for the rising 
rates of CS.31, 32 
•  Higher numbers of elective CS in first-time mothers may contribute to CS 
also in following deliveries.30, 32 
•  More multiple pregnancies resulting from in-fertility treatments and  
assisted reproduction may play a role.33 
•  Intense and very intense (“tocophobia”) fear of spontaneous childbirth is 
the most common maternal request for elective CS.32, 34 
•  In many countries, a defensive, risk-orientated obstetric practice and the 
doctors´  insurance premiums may have an influence on the choice of 
mode of delivery, where elective CS is an attractive alternative.32
•  A general increased tendency to risk avoidance and contemporary media 
flow are regarded playing an important part.32 
Fig 2. CS rates 2009 or nearest year before, modified according to OECD Health  
 Data 2011; WHO (2008a).
72.3.2 Cesarean section, short-term consequences
The short-term consequences for the newborn infant delivered by elective and 
emergency CS are well characterized.35-37 Compared to VD, there is an increased 
neonatal morbidity and mortality after CS. In the public opinion, it is not rarely 
assumed that CS prevents neonatal risks, because CS can be life-saving in certain 
situations. However, this is only true for seldom-occurring complications.38
The most common neonatal morbidity after elective CS is adverse respiratory 
outcome. It often appears as transient tachypnea of the newborn, but it also oc-
curs as respiratory distress syndrome with need of mechanical ventilation.36, 37 
Other adverse neonatal outcomes associated with an increased risk after CS are: 
•  admission to the neonatal intensive care unit 
•  need for cardiopulmonary resuscitation  
•  mechanical ventilation within 24 hours after delivery 
•  delayed adaption from fetal to neonatal circulation with persisting  
pulmonary hypertension 
•  newborn sepsis 
•  hypoglycemia 
•  prolonged hospitalization36, 39
The lowest morbidity and mortality is found in the gestational weeks 38 to 40.36, 37 
Nevertheless, the adjusted risk for mortality was doubled for infants delivered by 
elective CS compared to those born by normal VD.37 If CS is needed due to rea-
sons like breech position, multiple childbirth, placenta previa, psychosocial indi-
cation, former CS, small maternal pelvis, or large baby, near-term would be the 
best timing to be recommended.
2.3.3 Cesarean section, long-term outcomes
Several studies have shown that CS delivery is associated with an elevated risk 
of adult-onset immune disorders, neuropsychiatric conditions and obesity com-
pared to VD.40-42 Many of the studies on the long-term differences between elec-
tive CS and VD are prospective, population-based and adequately adjusted for 
known confounders. The epidemiological findings that indicate a long-term im-
pact of CS on the risk of adult-onset diseases may be limited. This is due to the 
heterogeneity of study results arisen from confounding variables hard to control 
for. These include use of anesthetic agents, antibiotics given, diet, hospital envi-
ronment, and the genetic diversity of the participants.40
Also, another important limitation in many studies is the difficulty to dis-
criminate between elective prelabor CS and emergency CS after onset of labor. 
With this limitation follows a possible underestimation of the effect of elective 
8prelabor CS, since some studies confined an association between the risk of dis-
ease later in life and elective CS.40, 43, 44
Cesarean section and risk for morbidity in later life
In a meta-analysis of 23 studies, Thavagnanam et al could demonstrate that in-
dividuals delivered by CS have a 20 % higher risk of developing asthma, both as 
children and adults, compared to those born vaginally.45 After adjustment for 
known confounders, such as maternal smoking, low birthweight, and duration 
of breast-feeding, the association was still consistent. A second meta-analysis by 
Huang et al, based on 26 studies, found a risk of 21 % after elective and 23 % after 
emergency CS for asthma later in life.46 Several possible explanations for the in-
creased risk for asthma have been discussed, such as preterm birth, lower birth-
weight, the hygiene hypothesis, prophylactic antibiotics, less breast-feeding and 
epigenetic modifications. A large Danish register study analyzed children born at 
term by CS under a 35-year period and found a 23 % increased risk for asthma.47
Allergic rhinitis and atopy have been reported to be more prevalent in chil-
dren born by CS.48, 49 There is evidence that children delivered by CS have an in-
creased risk of developing sensitization to food, although not all the studies could 
confirm the association.48, 50, 51 
Furthermore, a meta-analysis including 20 studies has shown that children 
born by CS have a 23 % higher risk of developing childhood-onset type 1 diabe-
tes compared to infants that are born vaginally.52 This association was not modi-
fied when it was adjusted for confounders such as maternal age, birthweight, ges-
tational age, birth order, breast-feeding, maternal diabetes, or family history of 
diabetes. 
Increased hospitalization rate due to gastroenteritis in early childhood has 
been related to birth by CS.53 A greater risk for celiac disease has been found in 
children born by elective CS43 and CS totally54 compared to VD. In the Danish 
register study there was an 20 % higher risk for inflammatory bowel disease.47  
Indications for an elevated risk of cancer, such as leukemia, neuroblastoma, and 
testicular cancer in children and young adults born by CS compared to VD 47, 55-58 
were described, certain leukemia even particularly in prelabor CS.57 Other stud-
ies could not report associations.59, 60
Furthermore, a higher risk of 46 % for immunodeficiency diseases has been 
detected in children and adults delivered by CS.47
Also, systemic connective tissue disorders and juvenile arthritis were associ-
ated with delivery by CS.47
Delivery by CS has been associated with a 36 % increased risk for aseptic ne-
crosis of the femoral head (Legg-Calvé-Perthes disease) later in childhood, also 
after adjustment for other risk factors such as breech position.61 
9Two meta-analyses, containing 9 and 28 studies, indicate a 33 and 34 % high-
er risk of obesity in childhood and adolescence, if the participants were born by 
CS.42, 62 Some studies regarding the risk of developing childhood obesity could 
find a difference between elective CS and emergency CS,63 other not.64, 65 
Additionally, previous studies have examined possible connections between 
CS and autism spectrum disorders with conflicting findings.41 A Finnish case-
control study suggests a possible association between autism and elective prelabor 
CS but not emergency CS.44
2.3.4 Bacterial gut colonization – the hygiene hypothesis
The “hygiene hypothesis” is one theory about underlying causes for the higher 
risk of developing immune-related diseases later in life after delivery by CS. It 
suggests that a too clean environment, especially in early childhood, may contrib-
ute to a greater risk of developing diseases related to the immune system, such as 
atopic diseases. It was proposed for the first time by Strachan, who observed an 
inverse correlation between hay fever and the number of older siblings.66
Newborn babies delivered vaginally are colonized by bacteria from the moth-
er’s birth canal and perianal region and the exposure to the bacteria may form 
their immune development.67 Newborns delivered by prelabor elective CS have 
an improper bacterial exposure and are predominantly colonized by bacteria 
originating from the hospital environment.68 They are also separated from their 
mothers for a longer time, resulting in delayed breast-feeding, altering the bacte-
rial colonization and growth in the neonatal gut.69 The divergent intestinal colo-
nization of infants born by CS may lead to abnormal neonatal immune responses, 
elongate postnatal immunological maturity processes, inhibit competent immu-
nological priming, and enlarge the risk for later immune disease.70
2.4 Epigenetics 
Conrad Waddington (1905-1975) is credited with coining the term “Epigenetics” in 
1942 as “the branch of biology which studies the causal interactions between genes 
and their products, which bring the phenotype into being”.71
Epigenetics supply mechanisms for the functioning genome and mediate ad-
aptations to a dynamic and changeable environment.72-74 Every human cell con-
tains about 20000 to 30000 regulated genes.75 Only a subset is expressed in any 
given cell. The expression is controlled by genome-wide epigenetic mechanisms. 
Today, the most accepted definition of epigenetics is ‘‘the study of chang-
es in gene function that are mitotically and/or meiotically heritable and that do 
not entail a change in DNA sequence”.76, 77 Strictly considered, it would only be 
DNA-methylation. But commonly, in addition to DNA-methylation, histone 
10
modification and non-coding RNA are also regarded as epigenetic mecha-
nisms.72-74, 77, 78
2.4.1 DNA-methylation
DNA-methylation is the most basic and best studied form of epigenetic modifica-
tion. DNA-methylation is a process by which methyl groups are added to cytosine 
in the DNA molecule forming methylcytosine, overwhelmingly most common in 
the context of cytosine-guanine dinucleotide (CpG). Cytosine (C) is followed by a 
guanine (G), held together by a phosphodiester bond (p).
In mammalian cells methylation occurs almost only on the fifth position of 
cytosine (Fig 3). Homocysteine, folate and cofactor cobalamin (B12) play an im-
portant role for the methylation of cytosine (Fig 3). In a reaction with methionine 
synthase, 5-methyltetrahydrofolate is transformed into tetrahydrofolate (THF), 
while transferring a methyl group to homocysteine and transforming it to me-
thionine. Methionine reacts with adenosine triphosphate to form S-adenosylme-
thionine, driven by the methionine adenosyltransferase. S-adenosylmethionine 
act as a donor of the methyl group (CH3) to cytosine (and other acceptors such as 
histones and other proteins).
Methylation of cytosine does not change the DNA sequence.79 The two con-
ceptionally different variants of DNA-methylation are “maintenance” and “de 
novo” methylation. Patterns of methylation are maintained through cell division 
and DNA replication by the maintenance methyltransferase DNA (cytosine-5)-
methyltransferase 1 (DNMT1), one of the so far known three mammalian DNA 
methyltransferases.79 Methylation “de novo” is independent of DNA replication 
and occurs i.e. in early embryogenesis and development. “De novo” methylation 
is catalized by the other two DNA methyltransferases DNMT3A and DNMT3B.79, 80
The human genome contains approx. 28 million sites (CpG-sequences),81 
Fig 3.  
DNA-methylation 
of cytosine at 
the fifth position 
with S-adenosyl-
methionine as 
methyl donor, 
THF: tetrahydro-
folate.
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where cytosine can potentially be methylated to e.g. produce specific cell lineages 
during development and in response to environmental exposures. Methylation 
patterns are thus specific for every cell type and allows or prevents gene tran-
scription. DNA-methylation of cytosine is generally associated with transcrip-
tional silencing when it occurs in gene promoters (Fig 4).79, 82 However, enhancer 
regions are also regulated by DNA-methylation and methylation of cytosine may 
allow or prevent gene transcription depending on context. In the mammalian ge-
nome, 60–80% of CpG sites are generally methylated.81 The DNA-methylation 
in mammalian DNA is not evenly distributed. Regions with a high frequency of 
CpG sites are called CpG islands. CpG islands usually encompass a region with 
at least 200 base pairs (bp) of densely populated CpG sites.83 About 10 % of all 
CpG sites are located in islands.84 Computationally, it is estimated that the hu-
man genome contains 29,000 CpG islands and about 60 % of human genes are 
associated with CpG islands.85 Around 70 % of CpG islands are located in gene 
promoter regions.86 CpG islands are predominant at transcription start sites of 
developmentally regulated genes and they are under normal conditions mostly 
unmethylated.84
 
 
 
 
Fig 4.
DNA-methyla-
tion in promoter 
CPG island pre-
serves activation, 
modified accord-
ing to Métivier 
et al .82
One example of DNA-methylation in a promotor region is the exon 17GR 
promoter region of the hippocampal glucocorticoid receptor gene in rat offspring, 
already mentioned in section 2.1.8 Rat pups raised by mothers who gave them 
better care in form of more licking and grooming were less stress sensitive. The 
expression of the GR mRNA is increased in the offspring of “good care taking” 
mothers or after manipulations that increase maternal licking and grooming, due 
to increased transcription of the hippocampal GR gene, coding for GR. The ac-
tivity of this promoter is enhanced due to maternal care.8, 87 Analysis of the indi-
vidual methylated cytosines within CpGs of the exon  17GR  promoter in hippo-
campus showed significant methylation differences in some of the 17 cytosines of 
the exon 17GR promoter depending on pup licking and grooming behavior by the 
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Fig 5.
Activation of the 
paternal Igf2 by 
methylation,  
modified according 
to Bell et al .91
rat mothers.8 DNA-methylation was significantly lower in the offspring of  “good 
care taking” mothers. This agrees with findings that decreased methylation of 
CpGs in regulatory regions of genes is associated with active chromatin structure 
and transcriptional activity.88
Enhancers are short (50-1500 bp) DNA elements that an activator (transcrip-
tion factor) can bind to and regulate the transcription of a certain gene.89 They 
are often located within the intron of the genes or neighboring genes and sel-
dom near to the promoter.90 The supposed mechanism for enhancer function on 
promoters is a direct interaction through “looping” the DNA, allowing an en-
hancer-promoter interaction.90 Proteins, e.g. transcription factors, are bound to 
both enhancer and promoter to start transcription when enhancer and promoter 
are located close to each other. Meanwhile methylation of CPG islands in promot-
er regions mostly correlates to a silenced gene,84 can methylation of enhancers 
result in activation of gene transcription.90 
One example is the methylated imprinting control region (ICR) in the en-
hancer of the Igf2 gene (Insulin-like growth factor 2), a growth promoting 
hormone during gestation.91 Every cell contains maternal and paternal DNA/al-
leles. In the paternal allele is the ICR of the enhancer methylated and the tran-
scription of the gene active. The maternal enhancer ICR is bound by CTCF 
(CCCTC-Binding Factor or Zinc finger protein), which acts as an insulator (reg-
ulatory element), preventing downstream enhancers from looping to and acti-
vate the Igf2 promoter on that allele.91 Methylation of the ICR on the paternal 
allele prevents CTCF from binding and acting as an insulator, and thus allows 
the downstream enhancers to activate the Igf2 promoter. The methylation of the 
ICR on the paternal allele also spreads into the H19 gene promoter and silencing 
it (Fig 5). 
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Fig 6.  
Oxidation of methylcytosine to hydroxymethylcytosine catalized by Tet protein, 
modified according to Hahn et al .92
5-methylcytosine              5-hydroxymethylcytosine
 Methylated cytosine can be enzymatically oxidized to hydroxymethylcyto-
sine by the catalyzer Tet protein (Fig 6). DNA methyltransferases cannot recog-
nize hydroxymethylcytosine, and DNA-methylation may be lost at CpG sites dur-
ing DNA replication.92 It can also be further oxidized and eventually replaced to 
cytosine in the absence of replication. The significance of 5-hydroxymethylcyto-
sine is still poorly understood. However, of all tissues the highest level of hydroxy-
methylcytosine is found in the human brain, up to 1 % of all cytosines in the hu-
man brain cortex are hydroxymethylated.93 It has been suggested that it could be 
an epigenetic modification by itself that may direct transcription through form-
ing chromatin structure and allowing transcription.92 The percentage of hydroxy-
methylcytosine is much lower in WBCs, and the genome-wide measurement of 
DNA-methylation by Illumina 450K (one of the methods, we applied) cannot dis-
tinguish between methylcytosine and hydroxymethylcytosine.
       The methods of gene-specific and global DNA-methylation measurement, 
we used, are described in chapter 4.2.
2.4.2 Histone modification
The other major epigenetic mechanism involves histone modifications, which in 
close interaction with DNA-methylation regulate chromatin structure and tran-
scription of the genome. Histones are highly alkaline proteins in eukaryotic cell 
nuclei. They form structural units called nucleosomes, which package and or-
der the DNA into building blocks of chromatin.74 Chromatin is the complex of 
nucleosomes that in their most compact form is called heterochromatin and in 
a “beads on a string” structure euchromatin (Fig 7). Eight subunits of histones, 
two each of H2A, H2B, H3, and H4 histones form the nucleosome. DNA wraps 
around the nucleosomes with approximately 147 base pairs (Fig 7). The compac-
tion of DNA contributes to structural support as well as serves functional roles.94 
Well-studied mechanisms of histone modification that occur at the histone tails 
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are acetylation, phosphorylation, and ubiquitination, which influences coiling of 
DNA around histones (Fig 7). 
Acetylation and deacetylation take place on the amino group of lysine by his-
tone acetyltransferases (HATs) and histone acetyldeacetylases (HDACs), respec-
tively.95 Through phosphorylation, a phosphate group is added to the amino acids 
serine, threonine, or tyrosine of the histone tail.96 
Ubiquitin is a small protein, consisting of 76 amino acids, first described 1975 
by Goldstein.97 Histone H2A was the first protein identified to be modified by 
ubiquitin. Ubiquitin is added to lysine, often as a single molecule, but also as mul-
tiple entities in ubiquitin chains. They are essential for normal cellular functions 
but the detailed mechanisms are still not completely understood.98
All these modifications control the packing of DNA in the nucleosomes and 
consequently influence the activity of transcription of genes.74, 85
Fig 7.  
Chromo-
some, genes, 
DNA, histone 
modification 
and methyla-
tion, modified 
according to 
Oropello et 
al .99
2.4.3 Non-coding RNA
About 90 % of the human genome is transcribed, but only 1–2 % of these tran-
scripts encode proteins, whereas the majority are transcribed as non-coding RNA 
(ncRNA).78 
Epigenetic function of different subclasses of ncRNAs are chromatin forma-
tion (packing of DNA) and regulation of gene expression at transcriptional or post-
transcriptional level.78 For example, the subgroup of small interfering RNA af-
fects the formation of heterochromatin directly. Another subgroup, microRNAs, 
mediates posttranscriptional gene silencing by binding to mRNA and prevent-
ing translation,100 and probably regulates gene expression also at the direct level 
of transcription.101 
There is substantial ongoing research about ncRNA. Some of their mecha-
nisms are well described and studied, others are still poorly understood.78
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2.5 Immune system and the newborn infant
The immune system is the body s´ defense system that protects against microbio-
logic threat, malignant cells, and other pathogens. Immunity is divided into two 
parts, the innate and the adaptive responses. The major difference is how fast and 
specific they may act.
The term innate immunity implies immediate host defense. Parts of the in-
nate immune system are neutrophils, monocytes, macrophages, complement sys-
tem, cytokines, and acute phase proteins. Innate immunity is unspecific and can 
even be found in the simplest animals.102
The adaptive immunity is distinguishing for the immune system of higher 
developed animals. Parts of the adaptive immunity are T- and B-lymphocytes, 
reacting antigen-specific. The adaptive response takes time, several days or weeks 
to develop, but is specific. The adaptive response develops memory, so that the 
following exposure leads to a more rapid response, although not immediate.102
Innate response
Neutrophil recruitment to the site of infection is a first major step in the innate re-
action.103 They are released from the stimulated bone marrow into the circulation 
and other body compartments and cause the so-called “classic” leukocytosis. The 
complement system, containing about twenty regulatory glycoproteins, forms 
transmembrane proteins in pathogen's cell membrane and that leads to death by 
osmotic lysis and enhances other parts of the immune response, i.e., inflamma-
tion and opsonisation.102 Other parts of the innate response are eosinophils pro-
tecting the host from parasitic infections, mast cells and basophiles, involved in 
severe immunological reactions, such as anaphylaxis and angioedema.102 Addi-
tionally, natural killer cells recognize abnormal cells and are alike lymphocytes 
but lacks specific antigen receptors. They are programmed to lyse the target, e.g. 
virus-infected cells.102 Finally, adhesion molecules, cytokines, and interferons are 
part of the cellular communication to work effectively where they are needed.
Adaptive response
Specific immunity consists mainly of T- and B-lymphocytes and their subpop-
ulations, functioning antigen-specific. The first step is the antigen presentation 
to and recognition by the antigen-specific T- or B-lymphocyte. That leads to cell 
priming, activation, and differentiation, and usually occurs in lymphoid tissues. 
The second step is effector response, either the activated T-lymphocyte leaves the 
lymphoid tissue and targets the disease site or the activated B-lymphocyte, also 
called plasma cell, releases antibodies into the blood and tissue fluids.102 The de-
velopment and formation of antigen-specificity and receptor rearrangement will 
be described in the next chapter, because it is prerequisite for TREC and KREC 
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measurement. 
Antigen presentation occurs in two ways. Antigens produced inside the cell 
(endogenously) form a complex with HLA/MHC class I molecules. Exogenous 
antigens (located outside the cell) are processed by special antigen-presenting 
cells, such as dendritic cells, B-cells, and macrophages. They are processing the 
antigen via different pathways inside the cell and express the antigen with MHC 
class II molecules. The two major types of effector T-lymphocytes are T helper (Th 
CD 4+) and T cytotoxic (Tc CD 8+) cells. CD 4+ lymphocytes detect only antigen 
presented by MHC class II and CD 8+ lymphocytes antigen presented by MHC 
class I. Th- and Tc-cells are functionally divided in subtypes Th 1/Th 2 and Tc 1/
Tc 2, and they can be distinguished by the cytokines they produce.102
B-lymphocytes produce different classes of antibodies, immunoglobulins 
(Ig). IgM is mainly found intravascular; IgG is the main antibody of the blood 
and tissues and IgA is especially found in mucosa secretions. The immunoglob-
ulins serve to neutralize toxins, prevent organisms from adhere to mucosal sur-
faces, activate complement, opsonize bacteria for phagocytosis, and sensitizes in-
fected cells for antibody dependent cytotoxic attack by killer cells.102 
Immune system in the neonate
Neonates have confined immunological memory and the difference to adults is a 
still developing immune system. They are more exposed to infectious factors and 
agents as their adaptive immune response is suboptimal.
Newborn infants have received placentally transferred maternal antibodies, 
IgG s´, which contribute to early defense against pathogenic microorganisms. This 
passive protection by maternal antibodies is after all short lived and diminishes 
over the first 6 months of life.104
However, diseases affecting the mother during pregnancy, like allergy, infec-
tions, the mother´ s nutritional state, and breastfeeding can have an impact on the 
developing immune system of the neonate and infant.104  For example, nutritional 
stress in mothers leads to increased level of the hypothalamic-pituitary-adrenal 
hormone and hence the following fetal exposure to lower thymic weight and re-
duced levels of cortical lymphocytes. It also activates an endogenous endonucle-
ase, which causes thymocyte apoptosis and altered B- and T-cell development.105 
The innate immune response for protection against infections is very impor-
tant in neonates, mostly due to their limited adaptive immune system.106 Neutro-
phils are a major part of the innate response, but they have poorer function, grade 
of amplification and mobilization104 and make neonates particularly liable to sep-
sis. Though there is a higher count of neonatal natural killer cells they are inferior 
in their function.107 The same applies for antigen-presenting cells.
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According to Basha et al,104 the available data about adaptive immune re-
sponse indicate a differential programming and functioning of neonatal T- and 
B-lymphocytes, compared to those of adults. Overall, it is characterized by an im-
maturity of their lymphocytes, a high presence of naïve recent thymic emigrants, 
low numbers of effector-memory T-cells, impaired Th 1 cytokine secretion and 
less strength of B-cell receptor signaling.
In summary, newborn infants have a higher vulnerability for infections due 
to a developing adaptive response compared to older children and adults. On the 
other side, they have a somewhat more efficient innate response and a passive 
immune protection through maternal antibodies, especially against virus. Addi-
tionally, breastmilk contains immunomodulatory cells, cytokines, exosomes and 
lactoferrin that help to protect newborns and infants from viral and fungal infec-
tions.104, 108
2.6  Hematopoietic stem cells,  
 naïve T-and B-lymphocytes, TREC and KREC
The development of hematopoietic stem cells during embryogenesis is a complex 
process and occurs in multiple anatomical sites, such as the yolk sac, the aorta-
gonad-mesonephros region, the placenta, and the fetal liver.109 From the mid-
dle of the second trimester, they colonize the bone marrow. In adults, all classes 
of blood cells are derived from bone marrow resident hematopoietic stem cells. 
The hematopoietic stem cells give rise to the blood cells through the process of 
hematopoiesis.110(Fig 8) Existing data from previous studies support the role of 
epigenetic mechanisms including DNA-methylation in the control of gene ex-
pression in hematopoiesis.111-114 
T- and B-lymphocytes develop from the common lymphoid progenitor in the 
bone marrow. B-lymphocytes remain in the marrow for their development, while 
T-lymphocytes migrate to the thymus. Both cell types develop antigen specific re-
ceptors. That happens through a process of random rearrangement and splicing 
of multiple DNA segments, coding for antigen binding areas.102 The rearrange-
ment arise early in the development of lymphocytes and leads to 108 T-cell recep-
tors and 1010  antibody specificities.115
A description of the T-cell receptor rearrangement and formation of T-cell re-
ceptor excision circles (TREC) follows in this passage, but the mechanism is simi-
lar for the B-cell receptor. 
T-lymphocyte differentiation occurs in the thymus and is characterized by 
rearrangement steps in the T-cell receptor (TCR) genes, resulting in the joining 
of variable (V), diversity (D), joining (J) and constant (C) gene segments,116 in the 
literature called for V(D)J rearrangement or recombination (Fig 9). 
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The T-lymphocyte receptor exist in two forms, the most common (> 85 %) is 
a heterodimer of an α and β chain with a constant and variable domain, a minor-
ity of T-cells express an alternate receptor, formed by variable γ and δ chains.102 
During each of the rearrangement steps, DNA fragments are deleted as circular 
excision products, TRECs.  They are excision products of the gene rearrangement 
in maturing thymocytes.116 TRECs are found in thymocytes and mature T-lym-
phocytes, but their role in the cell is not totally clarified. TRECs are assumed to 
have a high over-time stability, they cannot multiply and consequently are diluted 
during T-cell proliferation.116 The δRec-φJα TREC, is a late TCRD (T-cell receptor 
delta chain) deletion, produced by 70 % of developing human T-cells that express 
αβ TCRs.116, 117  The quantitative PCR amplification across the joined ends of the 
δRec-φJα TREC, that we used in paper III, are regarded to reflect the number 
of recently formed naïve T-cells. TREC containing naïve T-lymphocytes are al-
ready produced in the fetal thymus, but the highest output occurs at birth and at 
the end of the first week of postnatal life, around three-quarters of the T-cells are 
expected to be produced during or after delivery.118 It should also be noted that 
TREC containing T-lymphocytes can be very long-lived,119 and are not entirely 
representing recently formed T-cells by the thymus in later life.
During B-cell maturation, immunoglobulin κ-deleting recombination excision 
circles (KRECs) are produced, similar to the excision of TREC in the rearrange-
ment in T-lymphocytes.102 Two kind of KRECs are produced, the coding joint 
(cj) KREC, which remains within the chromosome, whereas the signal joint (sj) 
KREC is excised from genomic DNA. The (cj)KREC levels remain the same after 
B-cell division, whereas (sj) KRECs are not replicated during cell division.121 (sj) 
KRECs are a measure of newly matured naïve B-lymphocytes.
Determination of TREC and KREC levels is for example performed togeth-
er with the neonatal screening program. Levels of 10 copies/3 μL blood or lower 
for TREC and 6 copies/3 μL blood or lower for KREC at birth are considered to 
Fig 8. 
Schematic of 
hematopoietic  
development, 
modified accord-
ing to Forsberg 
et al.110
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be below normal values.122 Severe forms of primary immunodeficiencies display 
values below cutoff. Further, infants to mothers treated with immunosuppressive 
medication during pregnancy can show decreased levels at birth, which normal-
ize spontaneously after a few weeks.122 A wide range of infant’s conditions such as 
preterm delivery, multiple birth, malformations, different genetic disorders, neo-
natal leukemia, or maternal conditions such as autoimmune diseases, HIV infec-
tions, and other maternal medications are associated with low levels of TREC and 
KREC, even if they are not always below the cutoff.122, 123 Normal levels differ be-
tween several studies, but medians around 200 copies/μL blood (range, < 20 - > 
5000) have been reported.124
Epigenetic mechanisms, such as histone modification and DNA-methylation 
play a crucial role in the rearrangement of B-and T-lymphocytes.125, 126 For ex-
ample, under the process of antigen receptor gene assembly via V(D)J recombina-
tion in B-cells, recent research could present a DNA-demethylation after the first 
recombination step in the DJ junction.125 Further, during differentiation of naïve 
T-lymphocytes, the promoter-enhancer region of the interleukin-2 gene becomes 
demethylated.127
Fig 9.  
Exampel of T-lymphocyte receptor gene rearrangement in ß chain, modified according  
to Lang et al 120.
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3 Aims
The overall objective of this thesis was to study how mode of delivery and other 
perinatal factors can affect the epigenetic and immunological state of the new-
born infant.
The specific aims were:
•  To determine global DNA-methylation in white blood cells (WBC) of the 
newborn infant in relation to mode of delivery (Paper I).
•  To determine global and gene/gene region specific DNA-methylation – 
involving gene regions relevant for later immune function – in neonatal 
CD34+ hematopoietic stem/progenitor cells and relating the findings to 
mode of delivery (Paper II).
•  To study contributions from mode of delivery, infant and maternal char-
acteristics to levels of newly formed T- and B-lymphocytes (T-cell recep-
tor excision circles (TRECs) and κ-deleting recombination excision circles 
(KRECs) (Paper III).
21
4  Methods
4.1 Study subjects and blood sampling
4.1.1 Paper I
Subjects. All study participants were born at the delivery units at Danderyds Hos-
pital and at Karolinska University Hospital in Stockholm, in total 37 (17 girls) 
healthy newborn infants at term (gestational age 40 ± 2.6 weeks). Multiple preg-
nancy, maternal diabetes, hypertension, preeclampsia, medication during the in-
dex pregnancy, preterm delivery, neonatal asphyxia, malformations, chromo-
somal disorders, or congenital infection were all exclusion criteria. The mean 
maternal age was 33 ± 4.7 years, 11 out of 37 mothers were primigravida, one 
pregnancy had resulted from in-vitro fertilization and one mother smoked dur-
ing early pregnancy. All infants had normal birth weights (3699 ± 379 g). Spon-
taneous VD was the mode of delivery in 21 infants, whereas the other 16 infants 
were delivered by elective CS under spinal analgesia and before start of labor. 
Characteristics of the study subjects are shown in Table 1. 
Table 1. Subject characteristics, n = 37.
 VD CS
 n = 21 n = 16
Maternal age, years 31.8 ± 3.5 34.5 ± 5.6
Pre-pregnancy BMI, kg/m2 23.0 ± 3.1 24.0 ± 3.0
Parity, n 1.8 ± 0.7 2.0 ± 0.6
Gestational age, weeks 40.7 ± 3.3 38.9 ± 0.5
Birth weight, g 3723 ± 425 3668 ± 321
Girls/boys 9/12 8/8
 
Data are mean ± SD or proportions. There were no statistically significant differences 
between the two groups.
Blood sampling. From the umbilical cord, we sampled 5 ml EDTA blood directly 
after delivery. In conjunction with the metabolic screening test recommended for 
all infants born in Sweden, 2 ml EDTA blood was also sampled from a peripheral 
vein at day 3 to 5 of postnatal age.
DNA was extracted and methylation was measured by Luminometric meth-
ylation assay (LUMA, section 4.2.1 and 4.2.2).
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4.1.2 Paper II
In this study, we recruited pregnant women from the delivery units at Danderyds 
Hospital in Stockholm, Sweden. Exclusion criteria were multiple pregnancies, 
maternal diabetes or gestational diabetes, maternal hypertension, preeclamp-
sia, smoking during the index pregnancy, preterm delivery (gestational age < 37 
weeks), small-for-gestational-age infants (birthweight ≥ 2 SD below the mean for 
a Swedish reference population,128 neonatal asphyxia (Apgar score < 7 at 1 and 
5 minutes), malformations, chromosomal disorders, or congenital infection. No 
pregnancy resulting from assisted reproductive technology was included in the 
study.
For measurement of global DNA-methylation by LUMA in cord blood stem 
cells, we included 40 infants (18 girls) to women delivered by elective CS before 
the start of labor and under spinal analgesia, and as reference group, 49 infants 
(22 girls) born after spontaneous, non-assisted VD were included. After cell sepa-
ration and DNA extraction from stem cells (see section 4.2.1), 43 samples (18 CS 
and 25 VD) contained sufficient DNA (> 500 ng DNA) for methylation analyses.
In the VD group, the start of labor was defined as the time point at which 
the pregnant woman for the first time perceived regular (3-4 per 10 minutes) and 
painful uterine contractions. When admitted to the hospital, all women were 
asked about the time point (hours and minutes) for the start of labor. If labor had 
not started before admission, the start of labor was noted by the attending mid-
wife. Deliveries with induction of labor were not included in this study.
Indications for CS included previous CS, breech position, pelvic dispropor-
tion or maternal request. In the VD group, the median duration of labor was 14.5 
hours (range, 1 - 53 hours), and the median duration of ruptured membranes was 
4 hours (range, 0 - 17 hours).
Because of insufficient amount of blood samples from the first group, a sec-
ond group of infants was recruited. Cord blood from 12 infants (6 CS) was used 
to fill 1 Illumina 450K array (Illumina, San Diego, CA) to measure genome-wide, 
locus-specific DNA methylation. 
A misclassification error occurred regarding gestational age in the clinical 
records and one preterm infant (GA 33 weeks, CS group) was inadvertently in-
cluded in the genome-wide, locus-specific DNA-methylation analysis by Ilumina 
450K. The characteristics and results from this infant and mother were excluded 
from all statistical calculations comparing CS with VD. Consequently, 11 samples 
instead of 12 were analyzed from the Illumina 450K BeadChip.
The DNA content in 9 of these blood samples was sufficient for subsequent 
validation analysis using bisulfite pyrosequencing. To increase the numbers and 
power of the validation analysis, we recruited an additional 10 infants (4 CS) to 
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the second study group. There were no differences in maternal characteristics, 
gestational age (GA), sex distribution, or birthweight between the first and sec-
ond study groups.
In the whole cohort of 64 mothers, the median maternal age was 35 years 
(range, 23 - 43), the body mass index (BMI) was 22.8 kg/m2 (range, 15.9 - 38.4), 
and 17 of 64 mothers were primigravida. The GA was 39.2 (range, 37.6 - 42) weeks, 
and all infants had birthweights appropriate for gestational age (3667 g; range, 
2820 - 4915 g).
Mothers in the CS group (n = 27) were older compared to mothers in the VD 
group (n = 37) (37 (range, 25 - 43) vs 34 (range, 23 - 41) years; p = 0.03), and GA 
was shorter in the CS group compared to the VD group (38.9 (range, 37.7 - 39.9) 
vs 40.3 (range, 37.6 - 42.0) weeks; p < 0.001). Maternal and infant characteristics 
by mode of delivery for LUMA, Illumina, and bisulfite pyrosequencing groups 
are presented in Table (Paper II).
Blood sampling and preparation of hematopoietic stem/progenitor cells. 
From all participants, 15-20 mL blood was sampled in EDTA tubes from the um-
bilical cord directly after cord clamping. The cord was clamped after 30 seconds 
to obtain the targeted volume of cord blood. 
Blood cells were sorted and DNA from stem cells was extracted (Section 4.2.1).
4.1.3 Paper III
This population-based cohort was based on 7.174 singleton live-born infants, de-
livered in February through April 2014 in Stockholm county, Sweden. We re-
stricted the study population to infants born at 35 completed weeks of gestation 
or more, with Apgar scores ≥ 7 at 1, 5 and 10 minutes, and without any record of 
ICD-10 diagnoses for congenital malformations or neonatal morbidity (the Q- 
and P-chapters in ICD-10). After these exclusions of 1,160 infants, the study pop-
ulation comprised 6,014 infants and their mothers (Fig 1, paper III). 
Using the Stockholm-Gotland Obstetric Data Base, we retrieved maternal, 
pregnancy, delivery and infant characteristics.129 Information was prospectively 
collected; from the first antenatal visit that occurred during the first 13 gestation-
al weeks in 90 % of pregnancies, until postpartum hospital discharge.  
The main exposure, mode of delivery was categorized as non-instrumental 
VD, instrumental VD, emergency or elective CS. Elective CS was defined as CS 
before onset of labor. 
Maternal age was computed from the national identification number (moth-
er’s birth date) at the date of delivery. Parity and self-reported smoking habits 
were based on information obtained at the first antenatal visit. Maternal body 
mass index (BMI; kg/m2) in early pregnancy was calculated from self-reported 
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height and measured weight at the first antenatal visit. Maternal diabetes or hy-
pertensive disease was defined as recorded ICD-10 diagnoses: diabetes included 
pre-gestational (ICD-10 codes E10-E14 and O240-O243) and gestational diabe-
tes (ICD-10 code O244). Hypertensive diseases included pre-gestational (ICD-10 
codes I10-I15, O10, O11) and gestational hypertension (ICD-10 code O13), and 
preeclampsia (ICD-10 codes O14-O15). Gestational age was determined by the 
following hierarchy: a) date of embryo transfer (2.8 %), b) early second trimester 
ultrasound (96.1 %), c) date of last menstrual period (1.1 %), and d) from a post-
natal assessment (< 0.1 %). Birth weight for gestational age was estimated accord-
ing to the sex-specific Swedish reference curve for normal fetal growth.128 A nor-
mal birth weight for gestational age was defined as a birth weight between the 3rd 
and 97th percentiles. Postnatal age at blood sample was calculated by subtracting 
sampling date and time from birth date and time. 
The outcome variables, blood levels of TREC and KREC, were determined at 
the PKU laboratory at the Karolinska University Hospital, Stockholm, Sweden. 
TREC- and KREC-levels were analyzed as part of a neonatal screening project to 
detect severe combined immune deficiencies.122 Perinatal and maternal covari-
ates were categorized as presented in Table 2 (section Results) and S1 Table, paper 
III.
4.2 DNA methylation analyses
4.2.1. DNA extraction and cell sorting 
DNA was extracted using commercially available reagents (Nucleon BACC3 kit, 
GE Healthcare Europe GmbH, Freiburg, Germany). DNA quantification was per-
formed by using the NanoDrop ND-1000 (NanoDrop Technologies Inc./Thermo 
Fisher Scientific Inc., Wilmington, DE, USA) (Paper I and II).
In paper II we sorted umbilical cord blood cells with commercially available 
tools (Dynabeads positive isolation kit; Invitrogen by Life Technologies Corp, 
Carlsbad, CA) to separate CD34+ stem cells from other DNA-containing cells. 
CD34 (cluster of differentiation 34) is a glycosylated transmembrane pro-
tein130 and can be used for cell isolation, i.e. immunomagnetic methods as de-
scribed above. CD34 is expressed and represents a well-known marker for hema-
topoietic stem cells but also for early stages of progenitor cells,131 the first step of 
hematopoietic differentiation (Fig 8). Although we consistently applied the term 
hematopoietic stem cell or CD34+ hematopoietic stem cell in paper II, we are 
aware of that some of them already represent progenitor cells.
The isolated DNA were then frozen at -20°C until analysis by LUMA, Bi-
sulfite pyrosequencing or Illumina 450k methylation bead array. All DNA 
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methylation analyses were performed with the investigators blinded to mode of 
delivery.
There are two main technologies available to measure DNA-methylation. In 
the first method, total global DNA methylation is quantified by making use of 
methylation-sensitive restriction enzymes or immunoprecipitation with an an-
tibody against methylated cytosine.132 LUMA belongs to this group. The second 
method applies bisulfite-based treatment to convert unmethylated cytosine to 
uracil followed by sequencing or array technologies.132 Bisulfite pyrosequencing 
and Illumina 450k are based on the second technology.
4.2.2 LUMA (Luminometric methylation Assay) (Papers I and II)
LUMA was used for examining the global DNA-methylation. The basis of this 
method is DNA cleavage by methylation-sensitive or -insensitive restriction en-
zymes followed by a bioluminometric polymerase extension assay to quantify 
the degree of restriction cleavage.133 Isoschizomer HpaII and MspI (restriction 
enzymes with the same recognition sequence) endonucleases are used. Both en-
zymes have the recognition sequence CCGG. However, HpaII cleavage is inhib-
ited if the internal cytosine in the DNA is methylated (CmCGG), while MspI 
always cuts the recognition sequence, regardless of methylation status.134 
The DNA, treated with the enzymes leaving an extendable 5’-overhang, was 
then analyzed by a luminometric polymerase extension assay to quantify the 
amount of restriction cleavage by each of the enzymes. The relative amount of 
DNA methylation was defined as the HpaII/MspI ratio. The HpaII/MspI ratio 
would be 1 (equal amount of restriction) when DNA was completely unmethyl-
ated, and would approach 0 when DNA was fully methylated. Parallel reactions, 
one with HpaII and one with MspI, were run. To enable normalization between 
runs and for DNA input, EcoRI was included in all reactions. EcoRI has the rec-
ognition sequence GAATTC, and this cleavage was not affected by CpG methyl-
ation. After HpaII or MspI restriction at their recognition sequence, there was a 
resulting 5´ -CG overhang, whereas EcoRI restriction produced a 5´ -AATT over-
hang. Using the Pyrosequencing® platform, nucleotides were sequentially added 
(Fig 10). 
The entire LUMA analysis process was described in Methods in molecular 
biology.134 
The digestion reactions were run in a 96-well format using a PSQ96TM MA 
system (Biotage AB, Uppsala, Sweden). Peak luminometric heights were calculat-
ed using the PSQ96TM MA software.
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Fig 10. 
“Analysis of global DNA methylation with the LUMA assay. Genomic DNA of the test 
sample is cleaved with the two combinations of restriction enzymes, either HpaII + 
EcoRI or MspI + EcoRI. The extent of cleavage is then determined by a polymerase 
extension assay based on a four-step pyrosequencing reaction. After each nucleo-
tide dispensation, inorganic pyrophosphate (PPi) is released and converted to ATP by 
ATP-sulfurylase. Luciferin is converted by Luciferase and ATP to produce a proportional 
amount of visible light that is detected by a CCD (Charge-coupled device) camera. 
The amount of light is directly proportional to the number of overhangs produced by 
the respective restriction enzymes. The A and T peaks correspond to pyrosequencing 
Step 1 and Step 3, reflecting the EcoRI cleavage and should be equal. The C + G peak 
resulting from pyrosequencing Step 2 illustrates HpaII or MspI cleavage. The second 
C + G peak originating from Step 4 is an internal control that should be close to zero.” 
According to Karimi et al.133
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4.2.3 Bisulfite pyrosequencing analysis (Paper II)
Bisulfite pyrosequencing is based on DNA treatment with bisulfite which con-
verts cytosine to uracil, but leaves methylated cytosine unaffected (Fig 11).
Pyrosequencing (or regular sequencing) is thereafter applied to determine the 
bisulfite-converted DNA sequence, where specific CpG sites in the sequenced re-
gions can be assessed.135
 Fig 11.  
Conversion of cytosine to 
uracil, modified according to 
Tollefsbol(ed), Handbook of 
Epigenetics 2011.
 We selected CpGs, associated with the genes COLEC11, PCK2, PGBD5, and 
HLA-F. These genes had possible clinical relevance and/or CpGs exhibited the 
largest DNA methylation differences in relation to the mode of delivery in the ge-
nome wide analysis by Illumina 450k (see next section).
Genomic DNA (500 ng) was treated with sodium bisulfite (EpiTect bisulfite 
kit; QIAGEN, Valencia CA). One microliter of converted DNA (~10 ng) was ap-
plied as a template in the PCRs performed with the PyroMark PCR kit (QIA-
GEN). The entire PCR product and 4 pmol of the respective sequencing primer, 
and streptavidin sepharose high-performance beads (GE Healthcare), were used 
for pyrosequencing performed with the PSQ 96 system and the PyroMark Gold 
Q96 reagent kit (QIAGEN). The PyroMark CpG software 1.0.11 served for data 
analysis.
4.2.4 Genome-wide, locus-specific DNA-methylation analysis  
 (Paper II)
For the genome-wide and locus-specific DNA-methylation, we used the Illumina 
Infinium HumanMethylation450 BeadChip (450K), a cytosine microarray, based 
on the Infinium Technology.135  It is a quantitative DNA methylation measurement 
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of bisulfite-treated genomic DNA. Illumina 450K contains more than 480,000 
probes, targeting 99 % of genes and 96 % of CpG island regions.135 Illumina 450K 
can detect differences of 10 % or more in methylation with 99 % confidence.135
One chip was used, allowing for 12 samples (6 CS and 6 VD) from cord blood 
CD34+ cells to be analyzed. For each CpG and sample, the methylation level was 
estimated as a ratio (β) of the methylated signal to the sum of methylated and 
unmethylated signals. Before normalization, CpG sites located at known single-
nucleotide polymorphisms (list provided by the manufacturer) were discarded to 
avoid potential confounding by single-nucleotide polymorphisms at CpGs as well 
as probes located on the X and Y chromosomes. In addition, we discarded CpG 
probes with detection values of p > 0.01.136
To estimate the β values for the included CpG probes, a 3-step pipeline, de-
scribed as optimal, was used.132 Differential DNA methylation was computed by 
transforming β values into M values137 and using a software package for the anal-
ysis of gene expression microarray data, limma (Linear Models for Microarray 
Data), to define a linear model. Differentially methylated positions (DMPs) were 
defined as those that exhibited a 10 % or greater difference in the DNA methyla-
tion between the DMPs of the VD and CS groups, at a value of p < 0.01.
We chose the definition above to expose the most important DMPs, consid-
ering the following: 
(1) most differences in methylation are small 
(2) we investigated a lot of probes that required multiple testing
(3) we had only a small number of samples. 
We regarded a 10 % difference of DNA-methylation as a conservative door-
step for a greater difference in DNA methylation between CS and VD. We used 
the annotation from Illumina, and summarized the DMP information over genes 
by computing the number of probes for each gene, the number of DMPs, and how 
many DMPs were hyper- or hypomethylated.
4.3 TREC/KREC analyses (Paper III)
The original dried blood spots for the national neonatal screening program were 
used to determine TREC and KREC levels in 3.2 mm punches. DNA from a sin-
gle 3.2-mm punch of the dried blood disks was eluted into 24 μL of Generation 
DNA Elution Solution (QIAGEN) supplemented with 100 μg/mL yeast tRNA 
(Ambion), and 8 μL was subjected to real-time quantitative PCR (RT-qPCR) of 
TRECs, KRECs, and β-actin (ACTB) in a 96-well format.138, 139 TREC and KREC 
copy numbers were normalized per microliter of blood, assuming, that a 3.2-mm 
punch contains about 3 μL of whole blood. ACTB amplification was used to as-
sess the success of DNA extraction from the Guthrie cards. A cycle threshold for 
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TREC, KREC, or ACTB was fixed for automated data collection and analysis of 
the amplification during the exponential phase. By 10-fold serial dilution using a 
TREC-KREC-TRAC (TCRα subunit constant gene) construct containing plasmid 
and a β-actin sequence containing plasmid, Calibration curves were generated.139 
4.4 Statistical analyses
4.4.1 Paper I and II
Data were expressed as mean values and standard deviation (normally distribut-
ed variables) or median values and range (skewed distribution). Statistical anal-
ysis was performed using rank sum tests (Mann-Whitney U-test and Wilcoxon 
signed-rank test) and associations were tested for by calculating Spearman´ s cor-
relation coefficients. A p-value < 0.05 was considered statistically significant. 
All analyses regarding the locus-specific methylation were performed using 
the R statistics software.
The power calculation for the sample size in paper II was based on findings in 
paper I, in which DNA methylation (HpaII/MspI ratio) in the VD and CS groups 
had the mean values (SD): 0.30 (0.046) and 0.25 (0.022). Assuming normal distri-
bution and equal variance, the power calculation estimated 10 samples in each of 
the 2 groups would be needed to detect a difference in the DNA methylation of 
the same magnitude (2-sided test, 5 % significance level, 80 % power). The power 
calculation was performed in STPLAN version 4.5 (Obtained from MD Ander-
son Cancer Center. Available at: https://biostatistics.mdanderson.org/Software-
Download/SingleSoftware.aspx?Software_Id=41. Accessed June 12, 2014).
Spearman´ s correlation was used to compute the correlation between dura-
tion of labor and β value of each probe. Kruskal Wallis test was used to compute 
the significance of the difference between DMPs vs non-DMPs. Considering the 
all-probe correlations as a null distribution, we used as significance thresholds 
the 0.01 and 0.99 quantiles to identify significant correlations in the DMP set (Fig 
15, section Results 5.3).  
4.4.2 Paper III
Perinatal characteristics were described as numbers and rates, and compared by 
chi-squared test. Levels of TREC and KREC were log-transformed to achieve a 
normal distribution, and divided into quintiles, from low to high values. Chi-
square test was used to estimate differences in distributions of exposure (mode of 
delivery and other perinatal covariates) in relation to TREC- and KREC-quintiles. 
In addition, linear regression models were used to investigate whether the 
log-transformed TREC- or KREC-values were associated with our perinatal 
30
covariates. We also used logistic regression to calculate odds ratios with 95 % 
confidence intervals for the risk of having a TREC- or KREC-value within the 
lowest quintile (Q1), with the other quintiles (Q2-Q5) as the reference category. 
As postnatal age for blood sampling was strongly associated with TREC- and 
KREC-values, we investigated whether postnatal age for sampling modified asso-
ciations. A statistical interaction was pre-defined as an interaction term with p-
value < 0.05. Finally, sensitivity analyses were performed in the subset of infants 
with mothers without recorded diabetes and hypertensive disease.
The SAS software package version 9.4 (SAS Institute Inc., Cary, NC, USA) was 
used for statistical analyses. 
4.5 Ethical approvals
The studies were approved by the regional ethical vetting board at Karolinska 
Institutet in Stockholm (Paper I, Dnr 2007/37-31/3) and by the Regional Ethi-
cal Review Board in Stockholm, Sweden (Paper II and III, Dnr 2010/440-31/4; 
2012/1029/32, 2014/1292-31/4). 
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5  Results
5.1  Global DNA-methylation in white blood cells  
 after Cesarean section (Paper I)
At birth, global DNA-methylation was significantly higher in infants delivered 
by elective CS as compared to those born by normal VD (p < 0.001). Three to 
five days after birth, the difference in global DNA-methylation between the two 
groups was smaller and did no longer reach statistical significance (p = 0.10). In 
vaginally delivered infants, global DNA-methylation did not change between 
birth and 3-5 days of postnatal age (p = 0.55). However, in infants delivered 
by CS, DNA-methylation decreased significantly over the same period of time 
(p = 0.01) (Table 2, paper I and Fig 12). 
  
Neonatal DNA-methylation did not correlate to maternal risk factors (age, 
pre-pregnancy BMI, parity, maternal folate, and CRP-levels), perinatal risk fac-
tors (gestational age, duration of delivery, duration of ruptured membranes), or 
infant risk factors (sex, birth weight, folate, and CRP-levels) (p-values varying be-
tween 0.16 – 0.98). Accordingly, no multivariate analyses were performed.
Fig 12. 
Mode of delivery 
and global DNA-
methylation in healthy 
newborn infants. 
DNA-methylation 
in white blood cells 
expressed as HpaII/
MspI-ratio.
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5.2  Mode of delivery and global DNA-methylation in  
 hematopoietic/progenitor stem cells (Paper II)
CD34+ hematopoietic stem cells presented significantly more methylated DNA - 
determined by LUMA - in cells from CS infants compared to cells from VD in-
fants (p = 0.02, Fig 13). 
Global DNA methylation in the neonatal CD 34+ stem cells did not correlate 
with maternal characteristics (age, pre-pregnancy BMI, parity, duration of deliv-
ery, and duration of ruptured membranes) or infant risk factors (GA, sex, birth-
weight) (p-values varying from p = 0.13 to p = 0.91).
 
5.3  Mode of delivery and genome-wide,  
 locus-specific DNA-methylation in hematopoietic  
 stem/progenitor cells (Paper II)
We assessed locus-specific DNA methylation to detect specific genes differential-
ly modified in relation to mode of delivery. This resulted in the identification of 
343 DMPs exhibiting a difference in DNA methylation of 10 % or more (p < 0.01, 
Fig 14 and Suppl Table 2). The maximal locus-specific difference in DNA meth-
ylation in CD34+ stem cells from CS and VD infants was 40 %. Among the 343 
DMPs, there were 179 (52 %) associated with known genes and a majority of the 
DMPs were found in gene bodies. 
In contrast to the results from the global DNA-methylation analysis of hema-
topoietic stem cells (chapter 5.2), a majority (260 of 343, 76 %) of the DMPs in the 
neonatal CD34+ stem cells were found to be hypomethylated in CS as compared 
to VD (Fig 14). 
Fig 13.  
Global DNA 
methylation of 
CD34+ cells in 
cord blood was 
significantly 
higher in the 
group of infants 
born after elec-
tive CS com-
pared to infants 
born after VD 
(p = 0.02).
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 We found also a strong CpG-specific relationship between the duration of 
labor and locus-specific DNA-methylation in a subset of three identified genes 
(IRS1 (r = 0.91/p = 0.01), PRDX1 (r = 0.93/p = 0.01), and SORT1 (r = 0.86/p = 0.02), 
in addition to a general trend of higher correlation between duration of labor and 
DMPs (Fig 15). 
Fig 15 shows the distribution of the correlations; for all non-discarded probes, 
the distribution is centered around 0 (mean, –0.05; median, –0.04), whereas for 
DMPs, the correlation is larger (mean, 0.1; median, 0.17). The significance of the 
difference between DMPs vs non-DMPs computed by a Kruskal Wallis test was 
p < 0.001. 
 
Fig 14. 
A volcano plot of log-
transformed p values 
vs differences in DNA 
methylation (b-value) 
between CS and VD. 
Horizontal and vertical 
lines denote thresholds 
for the definition of dif-
ferentially methylated 
positions > 10 % dif-
ference in methylation, 
p < 0.01). Red dots 
indicate hypomethyl-
ated, blue dots indicate 
hypermethylated in VD 
vs CS.
Fig 15.  
The black line denotes 
the density of correlation 
between VD-methylation 
and duration of labor for 
all CpGs (null distribution), 
and the red line denotes it 
for all DMPs. The right-
shifted distribution for 
DMPs (red line) indicates 
hypermethylation. X-axis 
denotes the correlation; 
y axis denotes the kernel 
density estimate as com-
puted by density function 
in R.
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In these selected gene-associated probes, the degree of locus-specific DNA 
methylation in CS was similar to that in VD infants exposed to a short dura-
tion of labor, whereas at longer duration of labor in the VD group, the differences 
gradually increased (Fig 3, paper II).
For validation analysis, we replicated by bisulfite pyrosequencing eight CpGs 
associated with the genes COLEC11, PCK2, PGBD5, and HLA-F. The CpGs dis-
played the largest methylation differences by Illumina 450K in relation to mode 
of delivery and some of the genes may have relevance to processes in the immune 
system. From previous research are following facts about their function and im-
portance known:
•  COLEC11 gene encodes a member of the collectin family of C-type lectins 
that possess collagen-like sequences and carbohydrate recognition do-
mains. Collectins are secreted proteins that play important roles in the  
innate immune system.140
•  PCK2 gene encodes an isozyme of phosphoenolpyruvate carboxykinase, 
the phosphoenolpyruvate carboxykinase 2 (PEPCK-M). PEPCK-M is the 
first committed step of gluconeogenesis and glyceroneogenesis in the  
liver.141
•  PGBD5, the piggyBac transposable element derived 5, gene encodes an 
active DNA transposase. The transposase is expressed in the majority of 
childhood solid tumors, including lethal rhabdoid tumors.142
•  HLA-F (major histocompatibility complex, class I, F) gene encodes a HLA 
class I heavy chain paralogue. The function is still not clear but it is sup-
posed to bind a restricted subset of peptides for immune presentation and 
to activate cytotoxic T-lymphocytes.102  This gene has also been associated 
with a genetic predisposition to type 1 diabetes.143
The direction of methylation differences by bisulfite pyrosequencing in CS vs 
VD infants corresponded to the methylation analysis by Illumina 450K (Fig 4, pa-
per II). The sites of the DMPs for these genes varied with respect to the genes, in-
cluding locations in both intragenic and 5´ -untranslated region.
The differentially methylated CpG associated with COLEC11, was located 10 
bases upstream of exon 1. Two of the PCK2-associated CpGs were located in the 
5´ -untranslated region 180 and 185 bases upstream the transcription start site. 
The other 2 CpGs were located intragenic between exons 1 and 2. The differential-
ly methylated CpGs associated with PGBD5 had an intragenic location between 
exons 2 and 3, and the CpG in HLA-F was intragenic between exons 1 and 2. For 
the exact chromosomal location, see Suppl. Table 1, paper II.
The GREAT (Genomic Regions Enrichment of Annotations Tool), developed 
by Bejerano et al, is a web-based tool to associate biological functions to genomic 
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regions.144  The particular purpose of this analysis is to allocate biological mean-
ing to non-coding genomic regions by analyzing the annotations of the nearby 
genes.144 Three significant molecular functional annotations were revealed when 
analyzing our data: phosphoenolpyruvate carboxykinase activity, ligand-regulat-
ed transcription factor activity, and mouse double minute-2 binding. Further-
more, GREAT associated our gene set to more than 20 biological processes. The 
top 4 were: (1) immunoglobulin biosynthetic process, (2) regulation of glycolysis, 
(3) regulation of cellular ketone metabolic process, and (4) regulation of response 
to food (Fig 16). Two signaling pathways into cells were identified as differentially 
methylated: the Cadherin signaling and the Wnt signaling pathways.
 
Fig 16.  
Gene ontology term, biological process, identification by GREAT.  
A directed acyclic graph structure of the gene ontology hierarchy displays enriched 
nodes based on DMPs. Each colored node represents a significant biological process 
and the size of the node corresponds to the number of associated DMPs.
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5.4  Immune cell formation at birth, mode of delivery  
 and infant characteristics (Paper III)
Neonatal blood levels of TREC ranged from 16 - 622 copies (per 3.2 mm punch 
dry blood spot) with a median value of 166 copies. KREC blood levels ranged 
from 2 - 638 copies/3.2 mm punch, with a median of 97 copies. 
In the study population of 6,014 singleton infants born between 35 and 42 
gestational weeks, low TREC- and KREC-levels (within the first quintile) were 
more commonly found after elective CS, in male infants, after preterm birth (35 - 
36 week), in infants with low birth weight for gestational age, and when the blood 
sample was taken within the first 3 - 4 postnatal days (Table 2). In addition, the 
distributions of TREC-levels were left-shifted (towards lower levels) in infants de-
livered by elective CS compared to those delivered vaginally (Fig 17), in male com-
pared to female infants, after preterm (35 - 36 weeks) compared to term birth (37 
- 41 weeks), and in infants with low birth weight for gestational age as compared 
to infants with appropriate birth weight for gestational age (Fig 3 - 5, paper III). 
In contrast, rates of low TREC and KREC did not differ by any maternal charac-
teristics, such as age, parity, BMI and smoking (S1 Table, paper III). However, the 
rate of a low TREC-level was higher in infants of diabetic mothers, and the rate 
of a low KREC-level was higher in infants of mothers with hypertensive disease. 
The proportions of infants with TREC- and KREC-levels in the lowest quin-
tile decreased with infant postnatal age and therefore, all logistic regression mod-
els were adjusted for postnatal age at blood sampling. 
In the adjusted models, elective CS, male infant sex, preterm birth at 35 to 36 
weeks’ gestation and smallness for gestational age (SGA) were associated with in-
creased odds for a TREC-level in the lowest quintile (Table 2, paper III). Male in-
fants, infants born post-term (≥ 42 weeks of gestation) and SGA-infants had in-
creased odds for low KREC-levels, whereas elective CS was not associated with 
increased risk for low KREC (Table 2, paper III). Maternal characteristics showed 
no consistent associations with risks of low TREC or KREC levels (S2 Table, paper 
III). As mode of delivery may be related to gestational age, we tested whether ges-
tational age modified associations between mode of delivery and low TREC and 
low KREC, respectively. However, gestational age did not interact with mode of 
delivery (interaction terms p = 0.29 and p = 0.97, respectively). 
Given the strong and inverse association between postnatal age and low 
TREC- and KREC-levels, we investigated whether postnatal day for blood sam-
pling modified the associations between other perinatal covariates with regard to 
risks of low TREC- or KREC-levels. However, we found no statistical interactions 
between postnatal day for blood sampling and mode of delivery, gestational age, 
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infant sex or birth weight for gestational age, respectively.
Since rates of low TREC- and KREC-values were higher in infants to moth-
ers with diabetes and hypertensive disease (S1 Table, paper III), we repeated the 
logistic regression analyses within the subset of 5,681 infants to mothers without 
diabetes and hypertensive disease. Compared to the associations within the com-
plete cohort, similar results were found in these sub-analyses (S3 Table, paper III). 
        Low TREC  Low KREC  
  Total nb nb rate (%) p-value* nb rate (%) p-value*
Mode of delivery        
Elective C-section 640 176 (27.5) <0.01 156 (24.4) 0.02
Emergency C-section 452 100 (22.1)  96 (21.2) 
Instrumental vaginal 325 58 (17.9)  64 (19.7) 
Non-instrumental vaginal 4597 869 (18.9)  887 (19.3) 
       
Infant sex       
Male  3068 728 (23.7) <0.01 680 (22.2) <0.01
Female  2946 475 (16.1)  523 (17.8) 
       
Gestational age       
35-36  96 34 (35.2) <0.01 23 (24.0) <0.01
37-41  5457 1078 (19.8)  1061 (19.4) 
42  461 91 (19.7)  119 (25.8) 
       
Birth weight for gestational age      
SGA, <3 perc 74 25 (33.8) 0.03 36 (48.7) <0.01
AGA, 3-97 perc 5801 1153 (20.0)  1156 (20.0) 
LGA, >97 perc 137 24 (17.5)  11 (8.0) 
Missing 2 - -  - - 
       
Postnatal age at blood sample       
2  3147 809 (25.7) <0.01 894 (28.4) <0.01
3  1800 281 (15.6)  227 (12.6) 
4-10  1 058 112 (10.6) 82 (7.8) 
Missing 9 1 -  1 - 
* According to chi square-test.
 
Table 2. 
Perinatal characteristics of 6,014 singleton infants born at 35-42 weeks of gestation, 
and numbers (nb) and rates of TREC- and KREC-levels in the lowest quintile.
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Fig 17.  
Rates (%) of TREC values in quintiles (1=lowest quintile) after elective CS and normal 
non-instrumental VD, respectively. (Chi-square p-value < 0.001)
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6  Discussion
6.1 Finding and implications
Mode of delivery and DNA-methylation, an epigenetic mechanism
Accumulating evidence suggests that conditions, early in human life, i.e. in utero, 
during and immediately after birth, may affect future health.145, 146 The mecha-
nisms for such early imprints are presumptive epigenetic and may remain for 
many years.147 Genes may be equilibrated by these early epigenetic modifications 
for a response to future triggers, like infections, toxicants, aging processes etc. 
Accordingly, the frames for cellular and organ functions may be determined long 
before they are challenged.3 The increasing rates of CS, the conditions of birth 
stress during normal delivery, and the uncertainty about their long-term health 
consequences requested us to study epigenetic effects related to mode of delivery.
Our novel findings were:
•  At birth, global DNA-methylation in white blood cells in cord blood was 
significantly higher in infants delivered by elective CS as compared to 
those born by normal VD (Paper I).
•  Global DNA-methylation in neonatal CD 34+ stem/progenitor cells in 
cord blood was significantly higher in infants delivered by elective CS as 
compared to those born by normal VD (Paper II).
•  Genome-wide methylation analysis identified 343 CpG positions  
(179 associated with known genes) differentially methylated in cord blood 
CD 34+ hematopoietic stem/progenitor cells from infants delivered by 
elective CS, compared to those born by VD. The maximal locus-specific 
difference was 40 percent.
•  In these neonatal CD34+ cells, there was evidence for a relationship  
between the duration of labor and the degree of DNA-methylation in 
three specific genes in offspring.
•  The GREAT analysis revealed differential methylation in genes and  
associated biological processes regarding immunoglobulin synthesis,  
metabolism and apoptosis. 
Mode of delivery affects the epigenetic state of the newborn infant is con-
sequently a possible interpretation. Moreover, the GREAT analysis indicated a 
functional relevance. 
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The long-term risk for diseases associated with delivery by CS is of great im-
portance. CS rates are still accelerating and in many parts of the world is it a very 
common delivery mode, in some parts the most common.30, 40
The stress of being born vaginally is suggested to be of importance for physi-
ological transition and survival of the fetus leaving the womb and entering the 
outside world.12, 13 Infants born by elective CS before onset of labor desiderate 
this form of preparation and may therefore be maladaptive for those infants. In 
addition to the more obvious disadvantages for circulation and respiration, also 
activation of the immune system seems to be influenced. Previous studies have 
identified differences in immune biomarkers related to CS compared to VD, and 
even experimental findings suggest that mode of delivery can alter gene expres-
sion with a functional significance for the immune system.19, 40, 67, 148, 149
The hygiene hypothesis assumes that the missing colonization of the infant 
with maternal vaginal and gut flora after CS may inhibit the initiation of the im-
mune system of the newborn67 and the altered neonatal gut colonization leads to 
an increased risk, for example, to allergic diseases after prelabor CS.70  We found 
a correlation between the duration of labor and DNA methylation, indicating that 
methylation status at the start of vaginal birth is similar to that of CS infants (un-
exposed to labor and ruptured membranes), after which DNA methylation grad-
ually changes along with duration of delivery. In addition, we found no associa-
tion between duration of ruptured membranes and DNA-methylation. Thus, it 
suggests that our findings are linked to labor itself rather than to differences in 
bacterial colonization. 
However, altered gut colonization of the newborn infant may act through 
other epigenetic modification than studied by us. For example, the immuno-
regulatory effects of the gut microbiota may be mediated via histone modifica-
tion in the promoter of the Foxp3 gene, which enhances extrathymic induction of 
T-cells.150, 151 Previous studies indicate that maternal microbial transfer to the 
offspring may begin during pregnancy, providing a “pioneer microbiome”.152-154 
This early life environment of the intrauterine “pioneer microbiome” may im-
print the offspring microbiota in preparation for the much larger amount of mi-
croorganisms during VD.152 Thus, mode of delivery might affect the epigenetic 
state of the newborn infant may act both through maladaptive perinatal stress 
and altered microbial colonization of the neonatal gut. One central point in this 
context is that altered methylation associated with CS may create replication-her-
itable epigenetic marks, not immediately influencing gene transcription until an 
event later in life occurs and causes disease.
A growing number of recently published studies regarding DNA-methyla-
tion in human umbilical cord WBCs support our findings that environmental 
41
factors in early life may affect the epigenetic state. Maternal depression changed 
DNA-methylation in T-lymphocytes from the umbilical cord of neonates.155 
Maternal stress might also be associated with DNA-methylation changes at the 
gene sequence for the MEST gene, in umbilical cord WBC from newborn in-
fants.156 Idiopathic preterm delivery influenced the genome-wide, locus-specific 
DNA-methylation (by the Illumina 450K platform) at between 161 to 196 DMPs, 
and a number of them was still differentially methylated at 18 years of age.157, 158 
Growth restricted neonates had different DNA-methylation profiles, totally 839 
DMPs and 56 DMPs > 10 %  (β values by Illumina 450K) compared to AGA in-
fants in cord blood at birth.159 Prenatal physical activity of mothers was associat-
ed with reduced birth weight and DNA-methylation differences of a certain gene, 
PLAGL1, in cord blood samples.160 
DNA-methylation differences were also found in umbilical cord blood at 
birth in children with adipositas161 and ADHD symptoms162 at six years of age.
After our first published study (Paper I), two studies from other groups per-
formed analyses of global and single gene DNA-methylation and mode of de-
livery.163, 164 Virani et al163 investigated global DNA-methylation in cord blood 
from elective CS and VD infants using both LUMA and LINE1 analysis. Their 
cohort was substantially larger than ours, and they did not find differential global 
DNA-methylation after adjusting for a number of confounders, including smok-
ing. Franz et al164 used ELISA based on capture of methylcytosine and detection 
antibodies for global analysis. 96 single genes were analyzed by quantitative PCR 
using the Methyl-Profiler DNA Methylation PCR Array System. Their cohort was 
of the same range as ours and they did not find differential global DNA-methyl-
ation, but in two of 96 genes, ELA2 and the IRF1, was the DNA-methylation sig-
nificantly higher in the CS group compared to the vaginally born. It is important 
to note, however, that the LUMA method or other global analyses give the aver-
age methylation levels in the interrogated restriction sites throughout the genome 
and therefore will display only small changes if there are similar amounts of hy-
per- and hypomethylation, even if the changes themselves could be substantial. 
Although, we analyzed only global DNA-methylation in CD34+ hematopoietic 
stem/progenitor cells, we found yet a small, significant effect of mode of delivery 
on it. More importantly, using Illumina 450K, larger and bidirectional differences 
in DNA-methylation were found at hundreds of specific CpG sites in infants born 
by CS as compared to VD. The finding of significant different methylation of two 
single genes by Franz et al is in line with our locus-specific results by Illumina 
450K.165 Methylation differences in various cell types in whole blood166 as well 
as the different methylation analysis methods may contribute to divergent results 
from Virani et al. and Franz et al.163, 164
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Our findings in study I and II have no direct clinical implications today.  Giv-
en the growing evidence about CS, short- and long-term consequences, the cur-
rent Swedish guidelines regarding elective CS from 2011 should not be changed.167
A different epigenetic profile after CS may be a concernment for umbilical 
cord blood banks, with intention to transplant cord blood stem cells. Numbers of 
cord blood cells are influenced by mode of delivery.168 It is still unknown if deliv-
ery mode also could affect transplantation outcomes. 
Perinatal characteristics and lymphocytes at birth
Our third study found an association between mode of delivery, other perina-
tal characteristics and the number of newly formed, naïve T- and B-lymphocytes, 
determined by measurement of TREC and KREC. To our best knowledge, these 
associations have not been reported.
Our novel findings in paper III were: 
•  Delivery by elective CS was associated with a 32 % higher risk of hav-
ing low numbers of newly formed T-lymphocytes (neonatal TREC values 
within the lowest quintile) as compared to VD. 
•  Male sex, delivery at 35 to 36 gestational weeks, and being born SGA were 
associated with a shift towards lower TREC values (Lowest quintile). 
•  Male sex, infants born SGA or post-term (≥ 42 weeks of gestation) were 
also at increased risk of lower levels of B-lymphocytes (KREC values 
within the lowest quintile). 
Other associations between KREC values and mode of delivery and remain-
ing infant characteristics were absent. Moreover, we found no association be-
tween maternal characteristics or complications during pregnancy and high or 
low levels of TRECs or KRECs in the offspring. 
Several previous studies reported associations between being born and an 
immediate leukocyte release.169-173 Labor and the stress of being born is thought 
to be a major mediator in the establishment of immune function. Elevated levels 
of IL-8, soluble E-Selectin and Interferon-c levels were associated with progres-
sive increasing fetal stress during VD.19, 174 The stress of being born depends on 
mode of delivery, with much lower sympatho-adrenal activation and lower corti-
sol levels after elective CS than after VD.12, 14, 17 For that reason, mode of delivery 
seems to be an important factor for the postnatal adaption of the offspring im-
mune system.19
The findings of our present study extend the knowledge that mode of deliv-
ery can affect the adaptive immune system by means of lower levels thymic dif-
ferentiated T-lymphocytes. If the lower account of naïve lymphocytes is just a 
transitory neonatal phenomenon remains to be established. 
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The process of differentiation of T- and B-cells generates a pool of long-lived 
lymphocytes.175 If this pool is reduced already from start, it may have clinical con-
sequences in later life, i.e. when the individuals as child or adult become exposed 
to infectious organisms or develop immunologic conditions like immunodeficien-
cy and autoimmunity. Growing evidence links early fetal-neonatal living conditions 
and events to health in childhood and adult life.4 As described, CS is associated with 
a moderately increased risk for immune disorders later in life.47 Our results indicate 
that a reduced number of naïve T-cells after CS could be one possible link. We have 
not yet evidence and can only speculate if epigenetic mechanisms may be the basis 
for our findings. What we know is that DNA-methylation plays a role in the differen-
tiation and rearrangement process of T-cells.125-127 
Besides mode of delivery, male sex was associated with risk for low TRECs and 
KRECs after delivery. Cord blood from female infants has been found to contain 
higher levels of CD4+ T-lymphocytes, higher CD4/CD8 T-lymphocyte ratios and 
lower levels of CD8+ T-lymphocytes and NK cells, compared to cord blood from 
male infants, whereas the levels of B- lymphocytes is comparable in males and fe-
males.176, 177 Sex differences related to immune disorders have been described.178 
Diabetes type 1,179 asthma,180, 181 hypertensive disease,181, 182 and inflammatory bow-
el disease183 affect males differently, and mostly more often, than females. Whereas 
women are more often affected by rheumatoid arthritis184 and multiple sclerosis.185 
A disadvantage for male in immune responses to infectious diseases186 and outcome 
after sepsis187 has also been described.
Preterm babies are more vulnerable to infections and have functional deficien-
cies in their immune system.188 The influence of immaturity to the overall risk of in-
fection during the neonatal period is not completely understood, but prematurity is 
regarded to be the major risk factor for infections during this early period of life.189 
In paper III we found that also near-term birth, i.e., at 35-36 weeks, was associated 
with lower numbers of naïve T-lymphocytes. The analysis displayed also an asso-
ciation between smallness for gestational age and low TREC and KREC levels, re-
spectively. From previous studies, it is known that infants born small for gestational 
age have a significantly lower number of T- and B-lymphocytes190 and constitution-
al small for gestational age fetuses had a disproportionately smaller thymus.191 The 
findings implicate that gestational age and fetal growth should be considered when 
exploring associations between mode of delivery and the neonatal immune system, 
as well as associations between mode of delivery and later health-related outcomes. 
Additionally, low birth weight has been identified as a risk factor for adult diseases 
where inflammation plays a key role, namely hypertension, coronary heart disease, 
dyslipidemia, type 2 diabetes and obesity.192-195 
Besides, we also found that TREC and KREC levels altered over time from birth 
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and therefore we adjusted for postnatal age at blood sampling but we lacked informa-
tion beyond the first days of life to examine if our results present just a transient or 
maybe a permanent difference in the pool of naïve lymphocytes.
6.2 Methodological considerations 
Our three studies are all prospective observational cohort studies. Observational co-
hort studies are used to identify relationships between exposure and outcome, but 
cannot establish causality. Mode of delivery, i.e., elective CS compared to normal 
VD, was the main exposure in all three papers. Other covariates were maternal and 
infant characteristics, time of blood sampling (Paper I and III) and duration of labor 
(Paper II). Levels of global DNA-methylation (Paper I and II), locus-specific DNA-
methylation (Paper II) and TREC/ KREC levels (Paper III) were our outcome data. 
The prospective cohort study design has various advantages. The major strength 
is the accuracy of data collection and the possible disadvantage of a long follow-
up period was not relevant for our outcome data. In context of this thesis, the most 
important is that the study design allows hypothesis testing, detailed and in depth 
exploration of molecular mechanisms, blinding to participants’ exposure status, 
validation and replication analyses. Cohort studies can be applied if randomization 
is not possible which, was the case in this thesis. 
Internal validity
A study has high internal validity if it is unlikely that findings are explained by sys-
tematic or random errors. A systematic error is generally referred to as bias. Bias is 
independent of study size but can be reduced by carefully planning and designing 
the study.
Selection bias
Selection bias is the bias introduced by the selection of individuals for analysis, so 
that the obtained sample is not representative for the participants and data intended 
to be analyzed. 
In paper I and II, we have no population-based cohorts and participants were 
naturally not randomly assigned to the two modes of delivery. Parents were asked 
if they wanted to participate in our studies and those who gave consent and had no 
other exclusion criteria, were included. But we have no information about those who 
declined participation. Parents and infants not participating in the studies could be 
different from participating individuals. However, we have no obvious reason to be-
lieve that our study population in terms of delivery mode is not representative for the 
entire population and a possible difference would distinguish within the groups and 
contribute to selection bias.
The strength of study III is the population-based cohort design on a large number 
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of 7,174 singleton, live-born infants, delivered in a certain period of time, three 
month, and in a certain geographical area, Stockholm.
Information bias
Inaccurate recording and classification of exposures and outcomes can be re-
ferred to as information bias or misclassification.
In paper I and II, data were obtained from medical records, containing mater-
nal, pregnancy, delivery, and infant data. Medical records were written by health 
care staff not being aware of the data collection in paper I and II.
Another strength with study I and II were that the investigators who sorted 
subtypes of white blood cells, extracted DNA and analyzed DNA-methylation 
had no information about the exposures and participant characteristics. Blinding 
also applied to the TREC and KREC analyses in study III.
After DNA extraction, however, not all samples contained a sufficient amount 
of DNA for methylation analyses, so we did not receive any outcome data (Paper 
II). However, we could not find associations between infants or mothers char-
acteristics and insufficient amount of DNA. Reasons for this lower success rate 
were, above all, errors in blood sample management resulting in blood clotting 
and/or filling the test tubes with too few milliliters blood.
A limitation is that the genome-wide measurement of DNA-methylation by 
Illumina 450K cannot differ between methylcytosine and hydroxymethylcyto-
sine. Even if the percentage of hydroxymethylcytosine is suggested to be lower 
than one percent of the methylated cytosines, we cannot exclude that it may have 
contributed to some of our findings. On the other hand, a strength is that we also 
performed validation analyses for eight CpGs in four certain genes by bisulfite 
pyrosequencing to confirm our findings from the 450K Illumina analysis. Using 
bisulfite pyrosequencing, the direction of methylation differences found in CS 
and VD infants was consisting with the results by Illumina (Fig 4, paper II).  And 
in all three papers, the methods for measurement of DNA-methylation132, 134, 196 
and TREC/KREC122 are validated methods. 
In paper III we obtained data on mother, pregnancy, delivery and infant char-
acteristics from the population-based Stockholm-Gotland Obstetric Database. 
This database contains automatically retrieved information from the medical re-
cord system used in the region for all maternity, delivery and postnatal care units. 
The data were forwarded daily from the medical records to the database. It in-
cluded all prospectively collected and standardized information from antenatal 
care, all information from delivery and the postpartum period for mother and 
infant.129 Data misclassification is therefore unlikely.
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Confounding bias
Confounding refers to that the association between exposure and outcome is af-
fected by a third factor related to both exposure and outcome.
In the observational studies I and II on mode of delivery and DNA-meth-
ylation, we designed our protocols to reduce confounding by using restriction. 
Multiple pregnancy, maternal diabetes, hypertension, preeclampsia, smoking and 
medication during the index pregnancy, preterm delivery and SGA infants, neo-
natal asphyxia, malformations, chromosomal disorders, or congenital infection 
were all exclusion criteria. There were some minor differences in maternal and in-
fant characteristics between the two study groups in paper II: infants delivered by 
CS had on average 1 week lower GA than VD and the CS mothers were on aver-
age 3 years older. Contributions to differentially methylated CpG positions from 
higher maternal age and lower GA in the CS group compared to the VD group 
can therefore not be excluded, however, univariate analyses did not support such 
an interpretation.
To handle confounding related to mode of delivery and levels of TREC and 
KREC in the population-based cohort study III, we adjusted for risks for perinatal 
characteristics (mode of delivery, infant sex, gestational age, birth weight for ges-
tational age and postnatal age at blood sampling) and for maternal characteristics 
(age, parity, BMI, smoking, diabetes, and hypertensive disease).
Residual confounding refers to confounding exposures that cannot be con-
trolled for, i.e. confounding bias that remains after controlling for known/mea-
sured confounding factors in the design or analysis of a study. 
Despite the well-characterized cohort and standardized study protocol in pa-
per I and II and the large population-based cohort in study III, there are factors 
we could not measure or adjust for. For example, our database did not include 
time of cord clamping.  It cannot be ruled out that timing of cord clamping - and 
the following postnatal placental transfusion of blood cells to the infant – may 
have differed in relation to mode of delivery.
The outcome in paper III was TREC and KREC levels in peripheral venous 
blood and not in other tissues. Accordingly, a limitation could be that the birth 
stress may have affected the distribution of TREC and KREC containing lym-
phocytes between circulation and other body compartments,198 that we were not 
able to measure.
Effect modification
Effect modification or interaction is if the strength of an association changes via 
a third factor. The factor modifies the effect of the exposure. For example, gender 
is an effect-modifying factor if an exposure is associated with an outcome among 
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males, but not among females.
A consideration regarding effect modification in paper I was that differences 
in differential WBC count could have contributed to some of the observed differ-
ences in DNA-methylation between the two groups.  Also, if the calculation of the 
ratio between methylated and unmethylated DNA takes differences in total WBC 
number and DNA into account. There are larger birth-related shifts in neutrophils 
and monocyte counts in infants born vaginally as compared to CS, whereas dis-
tributions of lymphocytes in cord blood does not relate to mode of delivery.19, 197 
In study II, we could thereafter demonstrate that isolated CD34+ hematopoietic 
stem cells presented significantly more methylated DNA in cells from CS infants 
compared to cells from VD infants. It is therefore unlikely that a different mode 
of birth-related shift of neutrophils had a crucial contribution to our findings in 
study I.
Random error
Even in the absence of bias (systematic errors), chance could explain observed 
findings. Random errors depend on study size. The cohort analysis in paper III 
is based on a large study population, minimizing the risk of chance findings. The 
analyses in paper I and II were based on smaller samples of study subjects, and the 
possibility of random errors cannot be ruled out. However, the group differences 
were statistically significant on a probability level < 5 % and could be replicated 
suggesting that probability of chance findings was minimal.
External validity
While internal validity is related to the likelihood that observations are true for 
the study population itself, external validity refers to if results could be general-
ized to other, not here studied populations. Whether research can be generalized 
to other contexts depend on the degree of similarity between the study popula-
tion and populations in the other contexts.
Due to relatively small number of healthy infants in paper I and II, it is diffi-
cult to assess external validity. Observed findings need to be confirmed in larger 
studies.
Paper III was based on a large population-based cohort of singleton, live-born 
infants, delivered in a period of three month in a certain geographical area, im-
plying that results are applicable to the population of newborn infants in Sweden 
and other high resource countries.
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6.3 Ethical considerations
Study I and II were small observational cohort studies and participation required 
informed consent. The ethical considerations were related to the potential dis-
comfort of blood sampling. Sampling of cord blood (Paper I and II) does not cause 
any discomfort for the infant or mother. Peripheral blood sampling of mothers 
(Paper I) was performed together with venous catheter insertion during delivery 
and at day 3-5 by venipuncture of an experienced research nurse. The sampling 
was voluntary but all mothers accepted and no extra puncture was necessary. 
Infants blood sampling for DNA-methylation along with sampling for neonatal 
screening at day 3-5 (Paper I) was performed by an experienced neonatal research 
nurse. The ethical approval allowed one extra venipuncture if parents agreed and 
that was only necessary in a few cases. Levels of CRP and folate (Paper I) were 
assessed by a pediatrician and no value required clinical intervention. We also 
made sure to always answer questions and worries from the participants.
In study III, we used register data from the Stockholm-Gotland Obstetric Da-
tabase and already existing TREC- and KREC-levels, analyzed as part of a neo-
natal screening project to detect severe combined immune deficiencies,122 where 
parents had chosen to participate. Study subjects did not to do any extra tests. 
Ethical considerations are related to the registration itself. Individuals could be 
uncomfortable knowing that there is information about them available in regis-
ters. Studies of this kind are basically only possible in the Nordic countries be-
cause of our population-based research registers. Sweden therefore has a respon-
sibility towards the rest of the world to develop and test hypotheses that require 
both population-based approaches and high statistical strength. Utility should 
therefore considerer the potential risks of perceived integrity violation of the indi-
viduals present in the registry, who are not identified and only analyzed at group 
level.
All patient material in our studies has been handled with a high level of con-
fidentiality. In all our studies, results were presented at group level and no indi-
vidual result could be revealed. 
The presented studies comprise any clinical outcomes and no participant 
could be identified as an individual at risk.
Our findings about association of delivery mode, epigenetic modifications 
and de novo production of neonatal lymphocytes may be perceived as contro-
versial by the profession and by the public. Together with the other evidence pre-
sented herein, such knowledge might be able to worry and complicate women and 
their partner’s choice and necessity of delivery mode for their children. 
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7  Conclusions
The following epigenetic effects were found to be related to mode of delivery:
•  Global DNA-methylation in white blood cells of newborn infants  
delivered by elective CS was significantly higher as compared to levels 
seen after normal vaginal delivery.
•  Levels of global DNA-methylation in CD34+ hematopoietic stem/pro-
genitor cells of newborn infants delivered by elective CS were significantly 
higher as compared to those born vaginally.
•  Genome-wide, locus-specific DNA methylation in CD34+ hematopoietic 
stem/progenitor cells differed maximal 40 percent between infants born 
vaginally and those by elective CS, totally in 343 CpG positions, 179  
associated with known genes.
•  In three specific genes, we found evidence for a relationship between  
duration of labor and degree of DNA-methylation.
•  The GREAT analysis associated our gene set with the biological processes 
of immunoglobulin synthesis, metabolism and apoptosis.
Establishment of immune function at birth may be related to various perinatal 
risk factors, such as gestational age, mode of delivery and birth weight:
•  Infants born by elective CS had a 32 percent higher risk of having low 
number of naïve T-lymphocytes.
•  Delivery at 35 to 36 gestational weeks, being born SGA and male sex were 
also associated with a shift towards lower counts TREC+ T-cells. 
•  Infants born SGA, post-term, and of male sex were also at increased risk 
of low levels of B-lymphocytes (KREC values within the lowest quintile).
Given the rapidly increasing rates of elective CS worldwide and the greater risk 
for immune disorders later in life, our findings may have important implications 
for future research how mode of delivery affect the epigenetic state and birth- 
related surge in lymphocyte formation.
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8  Future Perspectives
Associations between CS delivery and immune system related disorders later in 
life requires further efforts to resolve issues on underlying mechanisms, causation 
and counseling. Our findings may contribute with pieces of knowledge to gradu-
ally solve this puzzle. Our results have so far no direct clinical impact and current 
Swedish guidelines regarding indication for elective CS should not be changed. 
However, awareness among both physicians and pregnant women about the asso-
ciations between CS and potentially poorer health in the offspring is warranted, 
and CS should not be recommended without an evaluation of harms and benefits, 
both for the mother and her infant.
Future research on CS and health effects in offspring should focus on longitu-
dinal aspects targeting epigenetic state of specific genes with immunoregulating 
functions. An important task would be to investigate whether any of the DMPs 
associated with the mode of delivery, i.e. in the HLA-F gene, retain their methyla-
tion profile in CD34+ hematopoietic stem/progenitor cells into adulthood.
Umbilical cord blood is used for transplantation purposes. Mode of delivery 
affects the epigenetic state of the hematopoietic stem/progenitor cells. However, 
to the best of my knowledge, it is unknown if that also could affect the transplan-
tation outcomes.
Study III identified several important risk factors for reduced number of 
naïve T- and B-lymphocytes in newborn infants. Future research should focus 
on longitudinal aspects of how, among other factors, elective CS influences the 
lymphocyte numbers and function in offspring. Does the lower quantity of newly 
matured lymphocytes relate to infections as well as disorders assigned to immune 
function later in childhood and adult life? We found quantity differences in naïve 
lymphocytes, does it affect the function as well? May there not be enough com-
binations of T-cell receptors, so that any subsequent invasion of microbes in the 
future cannot be responded to?
DNA-methylation plays undoubtedly a role in the rearrangement process 
of B-and T-lymphocytes and the thymic differentiation of T-lymphocytes.125-127 
Could mode of delivery via epigenetic mechanisms alter their function?
Finally, there are medical indications for CS and this should be acknow-
ledged. Induced “stress of being born” and restoring of microbiota could pres-
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ent possible interesting concepts for future research on elective CS. A small study 
inducing birth stress by terbutaline demonstrated better short-term adaptions of 
infants delivered by elective CS.198 The microbiome of infants after elective CS 
exposed to maternal vaginal fluids at birth was at one month of age similar to 
those delivered by VD.199 Larger studies based on these concepts regarding de-
scribed long-term consequences of CS, immune system, and epigenetics are need-
ed in this research area.
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9  Svensk  
 sammanfattning
Bakgrund
Epidemiologisk forskning har klarlagt att flera av våra stora folksjukdomar, så-
som kardiovaskulära sjukdomar, metabolt syndrom och cancer, inte bara beror 
på arvanslag och livsstil i vuxen ålder. Även störningar i människans tidiga ut-
veckling, som dålig fostertillväxt eller för tidig födsel, har visats spela stor roll för 
risken att drabbas av folksjukdomar som vuxen. Dessa relativt nya kunskaper har 
kommit att förändra synen på sjukdomars uppkomst.
Stressreaktionen av att födas vaginalt överskrider all annan känd fysisk stress 
som människan utsätts för under sin livstid. Vi vet att barnets omställning vid 
födseln underlättas av att fostret på detta sätt förbereds av värkarbetet. Ett barn 
som föds oförberett och med planerat kejsarsnitt har svårare att anpassa sig till 
yttervärlden lika bra och lika snabbt. Kortfristiga följder som adaptionsstörnin-
gar beträffande andning, cirkulation och hypoglykemi är välbeskrivna.
Andelen förlossningar med kejsarsnitt ökar snabbt, och i ett globalt pers-
pektiv är kejsarsnitt numera det vanligaste kirurgiska ingreppet bland kvinnor 
i fertil ålder. Det är framförallt andelen planerade kejsarsnitt före värkarbetets 
start som tilltar, vilket gör att allt fler barn föds utan den aktivering av kroppens 
försvarssystem som värkarbete och vaginal förlossning medför. Samtidigt har ep-
idemiologiska studier på senare år visat att barn och vuxna födda med kejsars-
nitt löper ökad risk för sjukdomar med ofta immunologisk grund, såsom astma, 
allergi, typ 1 diabetes, inflammatorisk tarmsjukdom, vissa typer av cancer, men 
också fetma och autism. Orsakerna till dessa samband är oklara. 
Epigenetik är läran om hur samma genetiska information i alla kroppens 
celler, kodad i DNA, uttrycks olika beroende på cellens funktion. Epigenetiska 
mekanismer reglerar aktivering eller repression av gener utan att förändra DNA 
sekvensen. DNA-metylering är den mest basala epigenetiska modifieringen. Me-
tylering sker nästan uteslutande på cytosin som följs av guanin (CpG). Andra epi-
genetiska mekanismer är modifieringar av histoner, såsom fosforylering, acety-
lering mm och förekomst av icke-kodande RNA (RNA som inte direkt leder till 
ett protein). Epigenetiska förändringar kan orsaka eller bero på sjukdom.
Djurförsök och studier hos människan pekar på att stressen vid födelsen och 
under nyföddhetsperioden kan förändra den epigenetiska koden och kan leda till 
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ändrade hormonnivåer av tex kortisol och minskad stresstålighet.
T-och B-lymfocyter är del av det adaptiva immunsystemet och utvecklas från 
hematopoetiska stamceller via progenitor celler i benmärgen. T-celler utvandrar 
till thymus och mognar där, medan B-celler förblir i benmärgen. Båda utvecklar 
antigenspecifitet genom en process kallad för slumpmässig omarrangering (rear-
rangement). Under denna process bildas bi-produkter kallade TREC och KREC. 
Genom mätning av TREC och KREC kan man få en uppfattning av hur många 
mogna T-och B-lymfocyter som förekommer i blodet. Ungefär tre fjärdedelar av 
alla naiva lymfocyter produceras i samband med och upp till en vecka efter för-
lossningen.
Syfte
Det övergripande syftet med denna avhandling var att studera om förlossningssätt 
och andra perinatala faktorer påverkar det nyfödda barnets epigenetiska och im-
munologiska tillståndet. De specifika målsättningarna var:
•  att studera graden av global DNA-metylering i vita blodkroppar i blod-
prover från navelsträng och perifer ven (dag 3 till 5) hos friska nyfödda 
barn förlösta vaginalt eller med planerat kejsarsnitt
•  att studera graden av global och lokusspecifik DNA-metylering i hemato-
poetiska (CD34+) stam- och progenitor celler från navelsträngsblod hos 
friska nyfödda barn förlösta vaginalt eller med planerat kejsarsnitt
•  att studera antalet mogna, naiva T- och B-lymfocyter hos friska nyfödda 
barn i förhållande till förlossningssätt, graviditetslängd och födelsevikt.
Material och metoder
Delarbete I and II är prospektiva observationsstudier av 37 (planerat kejsarsnitt 
=16) respektive 64 (planerat kejsarsnitt =27) friska nyfödda barn. Blodprover togs 
från navelsträngen och i studie I, även perifert på dag 3 till 5 efter födseln i sam-
band med nyföddhetsscreeningen. Global DNA-metylering mättes i vita blod-
kroppar med hjälp av metoden ”luminometric methylation assay” (LUMA). I 
studie II mättes global and genomvid, lokusspecifik DNA-metylering i hemato-
poetiska (CD 34+) stam- och progenitor celler med hjälp av metoderna LUMA 
och Illumina Infinium 450K. Validering skedde genom bisulfit-pyrosekvenser-
ing.
I delarbete III använde vi oss av prospektivt insamlade data från databas-
en Stockholm-Gotland Obstetric Data Base, innehållande barnets, moderns och 
förlossningens karaktäristika från 6.014 friska, nyförlösta barn in Stockholm. 
Dessa data länkades ihop med värden för T-cell receptor excision circles (TREC) 
och κ-deleting recombination excision circles (KREC), som mättes som del av 
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nyföddhetsscreeningen för immunbristsjukdomar. TREC och KREC värden rep-
resenterar mängden av mogna, naiva T- och B-lymfocyter.
I samtliga delarbeten gjordes statistiska beräkningar i syfte att kunna säker-
ställa icke-slumpmässiga skillnader i metyleringsgrad och lymfocyttal i förhål-
lande till exponeringsdata.
Delarbete I
Global DNA-metylering i vita blodkroppar från navelsträngen var ökat om man 
förlöstes med planerat kejsarsnitt jämfört med vanlig vaginal förlossning (p < 
0.001). DNA-metylering i leukocyter tagna i samband med nyföddhetsscreenin-
gen dag 3 till 5 efter förlossningen visade inte längre någon statistisk skillnad 
mellan dessa två grupper. Det fanns ingen korrelation mellan DNA-metylering 
och moderns, barnets samt övriga perinatala riskfaktorer.
Delarbete II
Global DNA-metylering i hematopoetiska stam- och progenitor celler från navel-
strängen var ökat om man förlöstes med planerat kejsarsnitt jämfört med vanlig 
vaginal förlossning (p = 0.02). Det fanns ingen korrelation mellan global DNA-
metylering och moderns, barnets samt övriga perinatala riskfaktorer.
Lokusspecifik DNA-metylering i CD34+celler visade en skillnad på > 10 % i 
342 CpG dinukleotider (p < 0.01). Största skillnaden var ca 40 % och 179 av 342 
olikmetylerade ställen var associerade med kända gener. DNA-metyleringen i tre 
CpG nukleotider visade ett samband med längden av värkarbetet. Validerings-
analysen med bisulfitpyrosekvensering av metyleringsskillnader i CpG dinukleo-
tider associerat med fyra kända gener, bekräftade fynden från Illumina Infinium 
450K-analysen. De genregioner med olikmetylerade CpG dinukleotider som vi 
fann, ingår i biologiska processer som omfattar immunglobulin syntesen, me-
tabolism och apoptos.
Delarbete III
Upprättandet av immunfunktion vid födseln kan relateras till olika perinatala 
riskfaktorer såsom förlossningssätt, gestationsålder, kön och födelsevikt. Friska 
nyfödda barn förlösta med planerat CS hade en 32 procent högre risk för att ha 
lägre antal nybildade, naiva T-lymfocyter. Även barn födda i gestationsvecka 35 
och 36, födda för lätta för gestationsåldern och av manlig kön uppvisade risken 
för lägre antal TREC-positiva lymfocyter. Dessutom hade nyfödda barn för små 
för gestationsålder och av manligt kön en förhöjd risk för lägre antal KREC-pos-
itiva lymfocyter.
Inga av fynden i delarbete I-III visar något orsakssamband mellan förloss-
ningssätt och sjukdomar senare i livet och den kliniska innebörden behöver un-
dersökas i fortsatta studier.
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Slutsatser 
Sammanfattningsvis demonstrerar fynden från våra arbeten att förlossningssätt 
påverkar epigenetiska modifieringar i form av DNA-metylering globalt i vita 
blodkroppar och hematopoetiska stam- och progenitorceller samt även genom-
vid, lokusspecifik i dessa CD34+ celler. Vårt senaste arbete ger för första gången 
också belägg för att förlossningssätt, kön, gestationsålder och födelsevikt i förhål-
lande till gestationsålder påverkar upprättandet av det adaptiva immunförsvaret i 
form av ett lägre antal mogna, naiva T-och/eller B-lymfocyter.
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